Investigations in Molecular Recognition Element Selection and Single-Wall Carbon Nanotube Properties by Williams, Ryan Martin
Graduate Theses, Dissertations, and Problem Reports 
2013 
Investigations in Molecular Recognition Element Selection and 
Single-Wall Carbon Nanotube Properties 
Ryan Martin Williams 
West Virginia University 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
Recommended Citation 
Williams, Ryan Martin, "Investigations in Molecular Recognition Element Selection and Single-Wall Carbon 
Nanotube Properties" (2013). Graduate Theses, Dissertations, and Problem Reports. 5011. 
https://researchrepository.wvu.edu/etd/5011 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research 
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is 
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain 
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license 
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, 
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. 
For more information, please contact researchrepository@mail.wvu.edu. 
i 
 
Investigations in Molecular Recognition Element Selection and 




Ryan Martin Williams 
 
A dissertation submitted to the School of Pharmacy at 





Doctor of Philosophy in Pharmaceutical and Pharmacological Sciences 
 
Letha J. Sooter, Ph.D., Chair 
Peter Gannett, Ph.D. 
Yon Rojanasakul, Ph.D. 
Linda Vona-Davis, Ph.D. 




Department of Basic Pharmaceutical Sciences 
Morgantown, West Virginia 
2013 
 
Keywords: Molecular Recognition Element, In vitro selection, SELEX, Aptamer, 
Prostate Cancer, Pesticides, Carbon Nanotubes, Single-Wall Carbon Nanotubes, 















Investigations in Molecular Recognition Element Selection and Single-Wall 
Carbon Nanotube Properties 
 
Ryan Martin Williams 
 
 The in vitro selection of Molecular Recognition Elements (MREs) is a powerful tool for 
identifying molecules useful in numerous applications.  This is achieved using the iterative 
Systematic Evolution of Ligands by EXponential Enrichment (SELEX) process.  This technique 
utilizes a large library of 109-1015 different molecules which is enriched for those that bind to a 
target of interest.  It also can be designed to enrich for molecules which do not bind to other, 
closely-related negative targets.  We have developed a novel variation of this process called 
Decoy-SELEX.  This enriches molecules that bind to the target of interest, but focuses on what 
the MRE should not bind to by using highly stringent negative selections with multiple targets.  
We have used this novel technique to identify separate MREs for three targets.  First, a single-
chain Fragment variable (scFv) antibody fragment MRE was identified that binds to prostate 
cancer cells but not benign prostatic cells.  This molecule will be useful in the specific detection 
and targeted therapy of prostate cancer.  Then, a single-stranded DNA (ssDNA) MRE was 
identified that binds to the herbicide atrazine but not other closely-related molecules.  This 
molecule will be useful in the rapid, field-use detection of environmental contamination by 
atrazine.  Finally, a ssDNA MRE binding to the pesticide malathion but not its metabolites was 
obtained.  This molecule will also be useful as an environmental sensor for malathion 
contamination. 
 Single-wall carbon nanotubes (SWCNT) are a relatively new class of materials with 
novel mechanical, electrical, and optical properties.  These properties are dependent upon the 
chirality and length of individual tubes, and can be altered with modifications, including 
chemical conjugates, DNA-wrapping, or protein adsorption.  Therefore, SWCNT have many 
potential uses, including incorporation into electrical or optical molecular sensors.  In order to 
determine the future potential of DNA-wrapped SWCNT in sensing applications, chirality 
identification, and purification, we tested their effect on the polymerase chain reaction (PCR).  
We determined the reaction-limiting concentration for different DNA sequences and SWCNT 
chiralities in addition to determining that DNA can be PCR-amplified directly from a SWCNT 
scaffold.  This study identified parameters important in future studies for SWCNT application.  
Additionally, we determined the effect of DNA-wrapped SWCNT on a green algae model 
organism compared to sodium cholate-wrapped SWCNT.  We determined that there was no 
effect of either type of SWCNT on algal growth at the concentrations assayed.  This is important 
as the manufacture and application of SWCNT increases, making the likelihood of 
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 The Selective Evolution of Ligands by EXponential Enrichment (SELEX) is a method of 
obtaining molecular recognition elements (MREs) that bind to a target of interest (Figure 1.1).  
This in vitro process is a powerful tool for selecting molecules useful in the specific detection or 
treatment of targets of interest.  Selectivity for a certain molecule or disease state can be ensured 
in designing the experiment with expected use of the final product being considered. 
 
Figure 1.1. Visual depiction of Molecular Recognition Element (MRE) binding.  A MRE is 
any molecule with strong and specific binding to a target of interest. 
 
 The SELEX, or in vitro selection, method obtains one or a few molecules that bind to the 
target with high affinity and specificity.  These MREs are selected from a large library of 107-
1015 random molecules.  SELEX was originally described independently by the laboratories of 
Gold and Szostak in 1990 (Ellington and Szostak 1990; Tuerk and Gold 1990).  These 
experiments selected RNA MREs that bind to proteins.  Both ribonucleic acid (RNA) and 
deoxyribonucleic acid (DNA) MREs have been selected that recognize a range of targets, from 
single ions and small molecules to nanoparticles and proteins (Paborsky et al. 1993; Breaker and 
Joyce 1994; Huizenga and Szostak 1995; Gugliotti et al. 2004).  These molecules are typically 
referred to in the literature as aptamers.  The same SELEX method has been used to develop 
antibody fragment and peptide MREs that bind to small molecules, proteins, nucleic acids, and 
nanoparticles (Boder et al. 2000; Schaffitzel et al. 2001; El-Mousawi et al. 2003; Kase et al. 
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2004).  The wide variety of MRE libraries and potential targets speaks to the numerous 
applications of SELEX. 
 The SELEX process uses a large library of random molecules that are incubated with the 
target of interest (Figure 1.2).  Those molecules that bind to this target are kept and amplified, 
while those that don't are discarded.  The amplified binding molecules are then incubated with 
negative targets, something the final MRE is designed to not bind to.  Those molecules that do 
bind these targets are discarded and those that don't are amplified and re-subjected to the target 
of interest.  This process of targeting and negative targeting is performed (rounds of selection) 
until one or a few high-affinity molecules remain in the library.  The selected MREs are then  
 
Figure 1.2.  Scheme depicting the iterative SELEX process.  A large pool of random 
molecules is incubated with the target of interest.  Non-bound molecules are washed away while 
bound are amplified and subjected to negative targets.  Non-bound molecules are amplified and 
re-subjected to the target under more stringent conditions. 
 
assayed for their binding affinity and selectivity before they are used for various applications.  
Regarding amino acid libraries, amplification typically occurs by use of a cellular host.  For 
DNA and RNA libraries, amplification occurs via the polymerase chain reaction (PCR).   
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 Molecular recognition elements have been selected that bind to molecules displayed on 
the surface of cells.  Originally performed by the Gold laboratory, DNA MREs that bind to the 
surface of red blood cells were selected (Morris et al. 1998).  This work showed the ability to 
select MREs that bind to molecules displayed on cell surface membranes in their natural state.  
Since that time, SELEX has been used to select MREs that bind to cell surface molecules that are 
differentially expressed on the surface of cells.  DNA ligands have been selected that bind to the 
vasculature of rat brain glioblastoma and not normal rat brain vasculature (Blank et al. 2001).  
Other nucleic acid MREs have been selected that bind to molecules on the surface of cancer cells 
but not other types of cells (Shangguan et al. 2008; Sefah et al. 2009; Zhao et al. 2009).  This 
type of MRE selection provides the dual benefits of binding to anchored molecules and taking 
advantage of differences in surface expression of cells for the therapy and diagnosis of disease. 
 Compared to DNA and RNA MREs, amino acid-based MREs potentially provide the 
stability and specificity of antibodies in vivo (Table 1.1) (Nelson 2010; Li et al. 2011).  
Additionally, the non-reversible nature of their target interaction and high binding affinity is an 
advantage in tumor cell targeting.  While having the positive attributes of antibodies in vivo, 
these MREs are selected in vitro.  Therefore, more control over their binding target is possible 
for the experimenter.  This includes the ability to preferentially select molecules which bind to a 
target but not a closely-related target.  In the case of differential cell SELEX, differential surface 
molecule expression is taken advantage of for MRE binding (Cerchia et al. 2009).  The result of 
amino acid MRE selection using differential cell SELEX is a molecule that has the advantages of 
antibodies with tunability in the experimental design.   
 Nucleic acid MREs have been investigated for their potential as in vivo diagnostic and 
therapeutic tools (Cerchia et al. 2002; Ireson and Kelland 2006; Lee et al. 2006; Guo et al. 2008; 
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Kim et al. 2009).  It is possible that they will be degraded in the body by nucleases, however 
there are modification strategies to overcome this (Kanwar et al. 2011).  In fact, Macugen 
(pegaptanib) is an anti-vascular endothelial growth factor (VEGF) nucleic acid MRE currently 
used in the clinic for macular degeneration (Moshfeghi and Puliafito 2005).  This drug, however, 
is only used in the relatively closed environment of the eye, while Avastin (bevacizumab) is an 
anti-VEGF antibody used in anti-cancer therapy (Jain et al. 2006).  Thus, there are modifications 
for using nucleic acid MREs in vivo, but amino acid MREs may be more useful. 
 Despite limited use in vivo, nucleic acid MREs have great potential for molecular 
detection in a variety of other settings.  This is due to their typically strong affinity and 
selectivity, as well as their ability to be re-used.  They can be denatured to release the target of 
interest after a binding event, and regenerated for further detection of the analyte (Ocana et al. 
2012).  Additionally, it is possible that nucleic acid MREs change their conformation upon 
binding their target, which can be capitalized on for detection transduction (Liu et al. 2010).  
Therefore, DNA and RNA MREs have a great deal of potential that is not found with antibodies 
or amino acid MREs.  
 There are advantages and disadvantages for DNA MREs compared to RNA MREs.  
Reports have shown that RNA MREs have a higher affinity for their target in general than DNA 
MREs (Potty et al. 2011).  This is likely due to the inclusion of a 2' hydroxyl in the ribose 
backbone of RNA.  However, nucleases that target RNA are much more abundant than those that 
target DNA, and thus identifying and applying RNA MREs is much more difficult.  
Additionally, PCR amplification of RNA is more difficult, as it must first be reverse-transcribed 
to DNA beforehand.  Thus, DNA MREs typically are more stable and suitable for most 
applications, though RNA MREs do have value. 
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 Discussed here is an overview on the creation of both amino acid and nucleic acid 
libraries for SELEX experiments.  Then, selections for different types of each and finally, their 
applications, are investigated.  Selection of antibody fragments for cell surface molecules and of 
nucleic acids for small molecules is focused upon. 
Table 1.1. Summary of the advantages of the four most typical types of MRE libraries. 
Type of Library Library 
Subtype 
Advantages 
Amino Acid  -In vivo stability 
-Diversity of 20 amino acids,  
 Peptide -Well-studied 
-Widely available libraries 
 Antibody 
Fragment 
-Antibody structure and diversity selectable in vitro 
-Final product can be made into a full antibody 
-Pharmacological profile similar to antibodies which are 
clinically available 
Nucleic Acid  -Large and diverse libraries easily obtained through 
combinatorial chemistry 
-Easily distributable (only need to know sequence to make 
your own) 
-Re-usable (can be removed from a target and regenerated for 
future use) 
-Easily modifiable 
 DNA -Easier to work with and less degradable than RNA 
-Very useful in molecular detection 
 RNA -Typically higher affinity than DNA 






1.2 Methodology Overview 
1.2.1 Amino Acid Library Creation 
 Amino acid libraries used in SELEX are typically displayed on the surface of living 
microorganisms.  Generally, coding regions are inserted into phage, bacteria, or yeast that 
encode for surface expression of the randomized library.  After expression of the library, it is 
incubated with the target cells of interest.  Those that do not bind are discarded while those that 
do bind are kept and amplified.  This amplification is performed by the natural replication of the 
microorganism.  This enriched library is then incubated with the negative target cells.  Those 
molecules that bind these cells are discarded while those that do not are amplified.  Between 
every few rounds, the diversity of the enriched library is assayed by DNA sequencing of the 
amino acid library-encoding plasmid.  The process continues until just one or a few specific and 
strongly-binding amino acid MREs are present.  These are then assayed for their binding, 
specificity, and stability.   
 1.2.1.1 Phage Display 
 Bacteriophage have been used to display amino acid libraries.  Libraries of short, random 
peptides that are displayed on the surface of phage have been used for SELEX experiments and 
are commercially available (e.g. Phage Display Peptide Library from New England Biolabs; 
Beverly, MA).  These typically consist of 7-15 random peptides displayed by fusion to a surface 
protein.  An example of this is the pIII protein of M13 phage, which is necessary for phage 
infection of Escherichia coli (Giebel et al. 1995).  Random nucleic acid codons are synthesized 
and inserted into the plasmid for protein fusion.  These libraries often consist of approximately 
109 different peptides.        
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 Additionally, a single chain Fragment variable (scFv) antibody fragment library has been 
constructed that is displayed on M13 phage (Pansri et al. 2009).  An antibody fragment (Fab) 
library has also been constructed that is fused to the surface protein D of bacteriophage lambda 
(Huse et al. 1989).  In this case, non-immune human antibody fragments are amplified from 
donors and constructed into a vector which displays the fusion protein on the virus surface.  It 
has been noted that phage lambda is more capable of displaying large antibody fragments than 
M13 (Vaccaro et al. 2006).   
 Phage displayed amino acid libraries offer the advantages of rapid screening and 
amplification for the SELEX process.  Selected phage are incubated with E. coli and plaques are 
produced.  The replicated phage are then subjected to the next round of selection.  The method 
used for SELEX is often panning (see below).  While rapid, this method is not as efficient at 
isolating specific molecules as fluorescent activated cell sorting (FACS) (see below).  A careful 
outline for the use of phage display has been published (Kay et al. 2001).  Rapid and efficient 
amplification coupled with detailed protocols allow phage displayed amino acid libraries to be 
useful tools in cell SELEX. 
 1.2.1.2 Bacterial Display 
 Another platform for amino acid library display is through the use of bacterial hosts.  A 
peptide display library of 12 random amino acids has been displayed as fusions to the E. coli 
flagellin gene (Lu et al. 1995).  This library contains approximately 5 X 1010 different peptides 
and is available commercially (Invitrogen; Grand Island, NY).  A library of the same size 
consisting of 15 random peptides has been displayed as a fusion to the E. coli outer membrane 
protein A (ompA) (Bessette et al. 2004).  These libraries offer the rapid and efficient screening 
necessary to create a MRE. 
9 
 
 Antibody fragment display has also been performed in bacterial systems.   A sub-library 
of scFv molecules in E. coli was created by PCR randomization of immune antibody fragments 
(Daugherty et al. 1998).  Additionally, scFv molecules have been expressed as fusions to the 
surface protein A of gram-positive Staphylococcus carnosus (Gunneriusson et al. 1996).  These 
constructs, however, have not been extensively explored for display of entire libraries or their 
use in SELEX experiments. 
 Bacterial display of amino acid libraries provides the benefit of rapid screening and 
amplification.  Furthermore, they can be used in both panning and FACS-based separation 
(Kronqvist et al. 2008).  While not as widely used as phage libraries, these libraries do not 
require multiple hosts, therefore increasing speed of the selection.  In addition, detailed protocols 
for their use are available (Lu et al. 2003).  These benefits render bacterial display of amino acid 
libraries a potential avenue for new developments in developing MREs. 
 1.2.1.3 Yeast display 
 Yeast display of amino acid libraries is a widely-used platform for generating MREs.  A 
library consisting of approximately 107 random twelve amino acid peptides has been constructed 
(Krauland et al. 2007).  It was formed as a C-terminal fusion to the Aga2p protein that is 
expressed on the surface of Saccharomyces cerevisiae.  This library has proven to be of use in 
the selection of MREs. 
 The use of S. cerevisiae to display antibody fragments has also been extensively 
explored.  This microorganism has been used to display a scFv library of approximately 109 
different antibody fragments (Boder and Wittrup 1997).  This library is freely available from the 
Pacific Northwest National Laboratory (PNNL; Richland, WA).  A Fab sub-library has also been 
constructed that displays on the surface of yeast (van den Beucken et al. 2003).   
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 Yeast display of amino acid libraries offers the advantages of use in FACS, as most 
include sequences for fluorescent protein tagging.  Importantly, eukaryotic yeast have the ability 
to perform post-translational modifications not available in bacteria or phage.  This allows for 
expressing the full diversity of antibody fragment libraries (Feldhaus and Siegel 2004).  The 
described yeast systems also offer easy secretion and purification of selected MREs.  Protocols 
for using these libraries are also easily available (Wang and Shusta 2005; Chao et al. 2006).  
These attributes allow the use of yeast in protein expression platforms to be an important tool in 
obtaining MREs by cell SELEX. 
1.2.2 Nucleic Acid Library Creation 
 The design of a single stranded nucleic acid library for in vitro selection largely focuses 
on determining constant regions for PCR amplification. These are often designed by individual 
laboratories, however both DNA and RNA libraries are available for commercial purchase (e.g. 
TriLink BioTechnologies; San Diego, CA).  A DNA library itself consists of two regions with 
known bases flanking a region with randomized bases.  A RNA library also contains a promoter 
region to allow for reverse transcription of the library before PCR amplification.  The greatest 
consideration in designing a DNA library is abrogating primer dimer formation and primer 
secondary structure effects.  It is important to determine whether designed primer sequences will 
bind to each other or themselves (hetero- and homo-dimers), or if their reverse complement 
sequences will bind to one another, as all four sequences will be in the amplification reaction.  
Additionally, highly favorable secondary structures of primer sequences may inhibit PCR, and 
thus needs to be avoided for all four primer sequences.  These can easily be interrogated using 
online PCR primer design software (e.g. Integrated DNA Technologies; Coralville, IA).  The 
size of the randomized region must next be determined.  This region must be designed to confer 
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the pool sufficient diversity, which can be represented by 4n, with n being the number of random 
bases in the pool.  For example, a pool with 34 random bases will have 434, or approximately 
2.95 X 1020, different possible sequences.  Thus, longer random regions contain exponentially 
greater possible sequence space.  In spite of this, longer random regions are more difficult to 
analyze for consensus binding sequences and are more likely to form secondary structures which 
inhibit PCR amplification.  Therefore, random regions are typically between 20 and 80 bases, 
making overall libraries shorter than 150 bases (Hall et al. 2009).  Longer regions are sometimes 
necessary, for example in obtaining catalytic MREs (Sabeti et al. 1997).   
     After design of the library for either DNA or RNA selections, it may be chemically 
synthesized using phosphoramidite chemistry (Hall et al. 2009).  The library must then be 
purified from remnants of the synthesis reaction, and PCR amplification conditions optimized.  
During this optimization step, the library may not amplify properly, and it will be necessary to 
re-design it to suit the researcher's needs.  Up to 1015 different sequences in the library are then 
incubated with the target of interest to begin the in vitro selection. 
1.2.3 Amino Acid Separation Methods 
 A necessity of the SELEX process is separating molecules that bind to the target from 
those that don't.  In cell SELEX, this is typically done by panning, magnetic sorting, or FACS.  
Often, a combination of these methods is used in order to most efficiently select MREs with high 
affinity (Table 1.2). 
 Panning, as used in cell SELEX, is a method of incubating the library with the target cells 
directly in the tissue culture well or flask.  The unbound microorganism-displayed molecules are 
simply aspirated or decanted.  The flask is washed typically three times taking care not to detach 
the target cells.  The bound molecules are then amplified by replication of their host.  This 
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process is most thoroughly described for phage-displayed libraries (Watters et al. 1997; McGuire 
et al. 2009) but has also been explored for yeast libraries (Wang and Shusta 2005).  For phage, 
the bound molecules must be eluted and plated on bacteria for replication.  In bacterial or yeast 
libraries, however, the appropriate microbiological media can be added to the cell culture flask or 
the human cells can be scraped from the flask. The enriched library-containing bacteria or yeast 
will amplify in this media, while any remaining human cells will not survive under these  
Table 1.2. Typical methods of separation in SELEX.  
Method Commonly Used With Advantages Disadvantages 
Panning Amino acid libraries, some 
filter-immobilized targets 










Typical for magnetic bead-
immobilized targets with 
nucleic acid libraries, MACS 
can be used for amino acid 
library separation 
High throughput Limited space if 




panning with no 
advantages 













Nucleic acid libraries; e.g. 
filter columns 




require many rounds 
Capillary 
Electrophoresis 







*MACS is Magnetic-Activated Cell Sorting. FACS is Fluorescence-Activated Cell Sorting. 
    
conditions.  Regarding negative selections, the unbound library molecules are removed by 
careful pipetting.  The collected host organisms are then placed under optimal growth conditions.  
This method of separation is robust for large libraries.  However, flocculation of the host 
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organisms or inefficient removal of non-binding molecules is possible.  This creates an enriched 
library that contains some molecules that do not bind to the target.  Therefore, panning is an 
efficient method of initial screening for the first few rounds of SELEX. 
 Magnetic sorting is another mechanism for separating binding for non-binding molecules.  
Often, magnetic-activated cell sorting (MACS) is used as a pre-enrichment procedure for similar 
reasons to those for panning.  In the case of non-cellular targets such as proteins, the target is 
typically attached to magnetic beads and the library is passed through the column (Rice et al. 
2006).  A variation of this used a B cell antigen to bind chronic lymphocytic leukemia cells to 
magnetic beads for use with a phage library (Takahashi et al. 2003).  The library molecules 
bound to the target are then eluted and replicated under appropriate conditions (or unbound 
molecules for negative selections).  While useful for robust screening, this method may be 
difficult for use in cell SELEX due limited space within the column when considering human 
cells and library host cells are present.  Therefore this method requires more preparation and 
greater potential for failure while performing the same pre-enrichment task as panning.  It is for 
these reasons that the use of MACS for cell SELEX in obtaining amino acid MREs is rare in the 
literature. 
 Fluorescence-activated cell sorting (FACS) is often used to select MREs that bind to 
molecules on the surface of cancer cells.  This method uses dual fluorescent labeling of the 
library and the target cells, which are removed from the culture flask.  After incubation together, 
this mixture is subjected to FACS, wherein the software is instructed to collect events 
corresponding to double fluorescence.  For negative targeting, collecting single fluorescent 
events corresponding to the library alone will render molecules that do not bind to the target.  A 
basic protocol for yeast-displayed scFv library SELEX using FACS has been described 
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(Feldhaus et al. 2003).  Additionally, a bacterial-displayed peptide library has been used for cell 
SELEX through the FACS method (Dane et al. 2006).  The greatest advantage of FACS is the 
tunability of separation parameters and extremely efficient enrichment of binding molecules.  It 
does, however, take considerably longer to screen very large numbers of cells.  This is 
exacerbated when using two largely different cell sizes, as is the case with human and bacterial 
or yeast cells.  Also, expensive equipment and expertise in operation is necessary.  Therefore, 
FACS is more efficiently used after the library has been enriched and it is not necessary to use a 
large number of host cells to ensure full diversity is represented. 
1.2.4 Nucleic Acid Separation Methods 
 Just as in selection of amino acid MREs, it is necessary to remove molecules that are not 
bound to the target of interest.  Typically, this involves immobilization of the target of interest 
onto a substrate.  There are separation techniques, such as capillary electrophoresis, that do not 
require this however (Mosing et al. 2005).   
 Immobilization of the target of interest is the most common form of nucleic acid MRE 
selection.  This can be done with magnetic beads for manipulation in solution by a magnet, 
allowing library molecules not bound to the immobilized target to be simply washed away 
(Stoltenburg et al. 2005).  This method has been successful for both protein and small molecule 
targets (Wang et al. 2009; Kim et al. 2010).  Additionally, both protein and small molecule 
targets have been immobilized onto non-magnetic beads for column chromatography-based 
selection of MREs (Jackson et al. 2009).  Protein targets can also be adsorbed onto nitrocellulose 
filter paper, however this is more difficult for small molecule targets (Ulrich et al. 1998; Sayer et 
al. 2002).  A variation of this technique is to immobilize the target onto a microfluidic chamber 
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for rapid MRE identification (Lou et al. 2009; Ahn et al. 2011).  Immobilization of the target 
typically occurs by conjugation through combinatorial chemistry approaches or adsorption.   
Other immobilization techniques have been developed, however they all ensure facile separation 
of bound from unbound molecules.  
1.3 Amino Acid Molecular Recognition Elements for Cell Surface Targets 
1.3.1 Peptide MREs 
 Molecular recognition elements selected from peptide libraries have been extensively 
explored.  Especially from phage display libraries, the cell SELEX procedure has been used to 
select MREs that bind specifically to tumor cells.  Peptides are short sequences generally less 
than 25 amino acids.  Libraries with a very large diversity can be formed drawing from the 
inherent diversity of the 20 amino acids.  A theoretical maximum for a 25 amino acid library is 
~1032 (2025) or 1.28 X 109 for a seven amino acid library.  However, typical construction 
techniques and reasonable working volumes typically limit library size to around 1010 molecules.  
Additionally, there is some bias in insertion of particular amino acids (Krumpe et al. 2006).  A 
breakthrough in peptide library construction was the introduction of codon phosphoramidites 
(Glen Research; Sterling, VA), which ensures no premature stop codon or insertional biases are 
present.  Compared to antibody fragment libraries, there may be less inherent structure within the 
MRE, but randomness is ensured. 
 Peptide MREs in cell SELEX have largely been selected through phage display methods.  
An example of this is the selection of peptide MREs that bound to the B-cell lymphoma line A20 
(McGuire et al. 2006).  This experiment did not use differential cell SELEX, but they were able 
to differentiate lymphoma cells from other normal white blood cells.  In another study, primary 
chronic lymphocytic leukemia (CLL) cells were the targets of phage selection using a modified 
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MACS protocol (Takahashi et al. 2003).  This study also did not use negative cell lines, however 
a panel of peptide MREs were selected that bound to different types of blood cells.  A study 
performed that selected peptide MREs for non-small cell lung cancer (NSCLC) cell lines also did 
not use a negative target cell (Chang et al. 2009).  One of the selected peptides, however, was 
successfully used for in vivo chemotherapeutic delivery studies.  It is therefore possible to select 
useful peptides without a differential component of the selection.   
 The likelihood of selecting one or a few specific MREs that are fit for their expected use 
is increased if negative targets are used.  One study selected for peptides that bound to the breast 
cancer cell line BT-474 but not the benign cell line MCF 10A (Shukla and Krag 2010).  This 
study even did a negative selection against the tissue culture flask itself.  This, however, seems to 
be inherent if negative selections are performed in the same type of flask as positive selections.  
The selected peptides did not bind to any of four benign cell lines that were used for binding 
studies.  They bound to some, but not all, tumor cell lines studied and internalized into some.  
Another study with breast cancer cells selected for peptides that bound to HER positive SKBR-3 
cancer cells but not HER negative MCF-10A benign cells (Abbineni et al. 2010).  The selected 
peptides showed homology to other ligands for HER2, however the actual cell surface target 
molecule was not determined.  Other studies targeting a follicular thyroid carcinoma cell line 
(Zitzmann et al. 2007) and separate colorectal tumor cell lines (Rasmussen et al. 2002; Kelly and 
Jones 2003) have been performed.  Separate studies using the metastatic prostate cancer cell 
lines LNCaP (androgen sensitive) and PC-3 (androgen insensitive) selected peptides that showed 
no real homology between the reported sequence sets (Romanov et al. 2001; Jayanna et al. 
2010).  As these peptide sequence families did not converge, it can be concluded that they were 
not binding to the same cell surface molecule.  Therefore it is likely these could be used together 
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to differentiate the two forms of prostate cancer and potentially define cell surface molecules 
present in one but not the other.   
 There also have been variations of the phage display peptide MRE selection process.  A 
bacterial peptide display library has been used to select molecules that bound to breast 
adenocarcinoma cells ZR-75-1 but not benign cells (Dane et al. 2006).  A variation on phage-
displayed peptide panning has been performed in a microfluidic system for semi-automated 
selection of MREs (Wang et al. 2011).  The above examples of using peptide libraries for 
selecting MREs express their potential in quick and efficient screening of random molecules to 
obtain diagnostically or therapeutically useful tools.   
1.3.2 Antibody Fragment MREs 
 Antibody fragment MREs have also been selected that specifically bind to tumor cells.  
Antibody fragment libraries can be in the form of scFv, Fab, or others.  These libraries typically 
have diversity on the order of 109-1010 molecules.  This well exceeds the natural potential 
diversity of the human immune system, which has a maximum of approximately 107 different 
antibodies (based on heavy and light chain combinations of genetic diversity).  Therefore, 
antibody-like MREs can be selected from libraries with much greater diversity than in vivo 
antibody production.  It is likely that strong and specifically binding antibody fragments will be 
selected for cancer cells using differential cell SELEX. 
 Multiple studies have selected MREs that bind to tumor cells but not normal cells or 
other types of tumor cells.  Two separate studies selected scFv MREs that bind to androgen 
insensitive prostate cancer cell lines.  One targeted PC-3 cells and did negative selections with 
normal prostate cell lines (Liu et al. 2004).  The other targeted the C4-2B cell line, which is 
derived from LNCaP cells that were used as a negative target (Conrad et al. 2009).  The selected 
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antibody fragments were used for separate purposes, but the differences in selection design make 
it unlikely the MREs bind to the same surface molecule.  Other studies have selected scFv MREs 
specific for melanoma cells (Kupsch et al. 1999), hepatocarcinoma (Yu et al. 2005), and ex vivo 
breast cancer tissue (Jakobsen et al. 2007).  Additionally, Fab MREs have been selected that bind 
to T-cell malignancies (Willemsen et al. 2008) and ovarian carcinoma cells (Figini et al. 1998).   
 Antibody fragment MREs offer the specificity and pharmacological characteristics of 
monoclonal antibodies.  Additionally however, they offer the selectivity and relative ease in 
production provided by the differential cell SELEX process.  Their multiple potential uses 
therefore make their selection a strong method for cancer cell studies using SELEX.  
1.4 Small Molecule Nucleic Acid Molecular Recognition Elements 
1.4.1 DNA MREs 
 Molecular recognition elements in the form of DNA have been obtained for a wide 
variety of targets. These include ions of lead, mercury, and arsenic, among others (Kim et al. 
2009; Chung et al. 2012).  They also include protein targets such as vasopressin, protein kinase 
C, VEGF, and many others (Williams et al. 1997; Mallikaratchy et al. 2006; Hasegawa et al. 
2008).  A variation of this includes the selection of DNAzymes, which are selected to have 
enzymatic activity (Zhu et al. 2012).  Another is the selection of double-stranded DNA MREs 
that bind to transcription factors (Sooter and Ellington 2004).   
 There have been a large number of MREs selected for small molecule targets for a 
variety of purposes.  These include the identification of molecules such as ATP within cells 
(Huizenga and Szostak 1995), detection of pharmaceutical or illicit drugs such as theophylline 
and cocaine  in biological contexts (Liu and Lu 2005; Chavez et al. 2010).  DNA MREs have 
also been selected for environmental monitoring and contaminant detection purposes.  Examples 
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of this include identifying MREs for pesticides such as acetamiprid or a variety of 
organophosphates (He et al. 2011; Wang et al. 2012).  It has been shown that small molecules are 
specifically able to intercalate between bases of a DNA MRE in a sequence-dependent manner 
(Lin and Patel 1997).  Additionally, normal antibody production against small molecule haptens 
require use of an immunogenic carrier, whereas in vitro selection does not, thus increasing 
specificity of the final binding element (Askonas et al. 1970).       
 DNA MREs offer a simplified and straightforward selection protocol, as discussed 
before.  Additionally, they are stable as compared to RNA MREs, plus regenerative ability 
compared to antibodies.  They are also very useful for molecular detection, as many references 
utilize them in this manner.  Therefore, selection of DNA MREs offers an ideal molecular 
detector for detecting small molecules in complex environments. 
1.4.2 RNA MREs 
 RNA MREs were historically the first to be identified (Ellington and Szostak 1990; 
Tuerk and Gold 1990).  These molecules were originally identified to bind to protein targets, and 
many more examples have since been reported.  There are also examples of the selection of 
ribozymes, which have catalytic activity often reliant on heavy metals (Wilson and Szostak 
1999; Robertson et al. 2004).   
 There have also been numerous examples of RNA MREs for small molecule targets 
(Codrea et al. 2010).  Similar to DNA, there have also been RNA MREs selected for ATP 
(Dieckmann et al. 1996).  Additional examples include antibiotics such as chloramphenicol, 
tetracycline, and kanamycin, among many other types of targets (Burke et al. 1997; Berens et al. 




 RNA MREs typically have a high affinity and specificity for their target of interest.  
Additionally, these molecules offer many of the same molecular detection applications that DNA 
MREs do.  They are, however, less straightforward to select and more likely to be degraded if 
used to detect their target in complex matrices.  There are examples of modifications at their 2' 
hydroxyl which lower their degradation, however this often negates their advantage of having a 
higher binding affinity (Cui et al. 2004; de-los-Santos-Alvarez et al. 2007).  It is therefore more 
straightforward with a higher probability of successful detector integration to select DNA MREs 
than RNA MREs. 
1.5 Molecular Recognition Element Applications 
1.5.1 Amino Acid Molecular Recognition Element Applications 
 1.5.1.1 Therapeutics 
 Amino acids in the form of monoclonal antibodies have been widely used as therapeutics 
(Brekke and Sandlie 2003).  Well-known examples include trastuzumab (HerceptinTM: 
Genentech Inc.; San Francisco, CA) for HER2 positive breast cancer treatment and bevacizumab 
(AvastinTM: Genentech Inc) that binds to vascular endothelial growth factor (VEGF).  These 
examples, among others, show the potential of amino acid-based therapeutic intervention. 
 Peptide therapeutics have been developed and used for a variety of diseases.  Examples 
of these are to inhibit infection (Oyston et al. 2009) and inflammatory diseases (Vally et al. 
2006).  A review of therapeutic peptides obtained by phage display selection is available (Ladner 
et al. 2004).  Examples of commercial peptide therapeutics include HumulinTM (Lilly; 
Indianapolis, IN) for diabetes treatment and leuprolide (LupronTM: Abbott Laboratories; Abbott 
Park, IL) for metastatic prostate cancer treatment.  Peptides obtained by cell SELEX are 
therefore possible alternatives to antibodies for cancer treatment.   
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 Antibody fragments have also been used therapeutically.  As of 2009, approximately 90 
scFvs had been patented in the U.S., with about 30 being specifically for cancer therapeutics 
(Pucca et al. 2011).  The humanized h5G1.1-scFv specific for complement protein C5 
(pexelizumab: Alexion Pharmaceuticals; Cheshire, CT) has undergone clinical trials for its 
ability to reduce myocardial infarction after coronary artery bypass surgery (Smith et al. 2011).  
This molecule was not selected by SELEX, but was engineered from a previously-selected 
monoclonal antibody (Evans et al. 1995).  The results of clinical trials are mixed (Lin 2011), 
however the pharmacological profile of the antibody fragments does appear to be safe (Fitch et 
al. 1999).  It is just one of 19 scFvs to reach clinical development as of 2010 (Nelson 2010).  
There have also been 22 Fabs to reach clinical trials, 3 of which have been approved (Nelson 
2010).  While some of these antibody fragments were engineered from monoclonal antibodies, it 
is clear that scFv treatments obtained from SELEX will be useful and more specific for cancer 
treatment. 
 Another scFv molecule that binds to the HER2 receptor on the surface of tumor cells has 
undergone clinical trials.  The antibody fragment was produced similar to the previous one, 
however it was conjugated to exotoxin A (scFv-ETA) (Wels et al. 1992).  The results of the trials 
proved safe, and the drug was moderately effective (von Minckwitz et al. 2005).  This use of 
antibody fragments in tumor cell treatments shows the potential for specific drug delivery of 
various therapeutics. 
 The use of amino acid MREs is clearly a potentially fruitful field.  The experimental 
tunability for selectivity and in vivo stability has been previously demonstrated.  Recently, 
theranostics, or the dual use of single molecules for therapeutic and diagnostic purposes, has 
become popular (Goldenberg et al. 1990).  There is clearly the possibility of using amino acid 
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MREs that have been conjugated to contrast materials as in the previous study.  The use of 
MREs obtained by cell SELEX in therapeutics and/or diagnostics has only begun to be explored 
but represents great potential. 
1.5.1.2 Disease Detection 
 Amino acid MREs for detection of disease is a potential clinical application of these 
molecules.  For biomarker-based cancer detection, blood is typically extracted and subjected to 
immunoassays with monoclonal antibodies.  There also lies the potential for magnetic, radio-, or 
fluorescent labeling of these antibodies for diagnostics.  Antibodies used in these assays do not 
always bind to molecules that represent disease states.  For example, anti-PSA antibody used in 
prostate cancer detection has a false-positive rate over 75% (Thompson et al. 2006).  These uses 
make it important to obtain molecules that specifically detect malignant cells.   
 Initial research using peptide MREs obtained by SELEX have been promising.  Ex vivo 
human and in vivo mice studies using colon cancer-specific peptides have been performed (Kelly 
et al. 2004).  Using radiolabeled and fluorescent peptides, favorable pharmacological profiles 
and detection were observed.  Similar results were found using an anti-prostate cancer peptide 
selected by phage display (Zitzmann et al. 2005).  While not extensively explored for clinical 
use, peptide MREs may have great diagnostic potential. 
 Similar studies to those performed with peptide MREs have been done with antibody 
fragments (Goldenberg et al. 1990).  Another potential use of antibody MREs is in ex vivo 
diagnostics such as immunoassays or microfluidic cell capture.  Though using a monoclonal 
antibody, previous studies have shown the ability to capture circulating tumor cells with 
antibodies in a microfluidic device (Goldenberg et al. 1990).  There is the obvious potential for 
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application of antibody fragment MREs to a similar device.  These and other uses make the 
diagnostic potential of amino acid MREs extremely important. 
 1.5.1.3 Surface Molecule Elucidation and Discovery 
 Whether the selected MRE is nucleic or amino acid, it can be used to learn more 
information about its target cell.  An important attribute of cell SELEX is that no a priori 
knowledge of the cell surface molecular target is necessary.  It is also likely that cells in disease 
states will express surface molecules differently than normal cells.  No previous knowledge of 
this differential expression is necessary however, because the differential cell SELEX process 
will take advantage of this fact in selecting MREs.   
 The cell SELEX process has been used to select MREs which aided in identification of 
their own surface ligand.  DNA MREs have been selected that bound to tenascin C 
overexpressing cells and not unaltered cells (Daniels et al. 2003).  As predicted, the MREs bound 
to tenascin C.  Another study determined that ICAM-1, an intercellular adhesion molecule, was 
the target of scFv MREs selected on androgen-insensitive prostate cancer cells (Conrad et al. 
2009).  DNA MREs have also been used to discover new proteins expressed on the surface of 
dendritic cells (Berezovski et al. 2008).  These works show that overexpression of a surface 
protein does allow MRE selection against them.  Additionally, novel or confirmatory roles of 
previously described molecules can be determined.  There also lies the potential for discovery of 
new cell surface molecules or biomarkers.  This use of MREs is potentially very important for a 
fundamental understanding of disease proteomics. 
1.5.2 Nucleic Acid Molecular Recognition Element Applications 
 Nucleic acid MREs have great potential in multiple settings.  Predominant among these is 
analyte binding in biosensors. Both DNA and RNA MREs have been incorporated into sensors 
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(Cho et al. 2009).  Typically, these come in the form of optical, electrochemical, or mass 
sensitive sensors, sometimes with the incorporation of various nanoparticles for signal 
transduction (Song et al. 2008).  As noted previously, nucleic acid MREs function well in this 
setting because they can be obtained for most targets, can be modified and incorporated into 
devices, are relatively stable, often change shape upon ligand binding, and are reusable. 
 Nucleic acid MRE-based sensors have been developed utilizing many different 
modalities.  For example, sensors for just ATP have been developed using DNA MREs 
integrated into many types of sensors, including those utilizing field-effect transistors (Goda and 
Miyahara 2012), fluorescent detection (Urata et al. 2007; Wang et al. 2008), quantum dot 
luminescence (Huang et al. 2010), surface-enhanced Raman scattering (Li et al. 2012), carbon 
nanotubes (Zhang et al. 2010), microbalances (Ozalp 2011), electrochemical transducers (Zuo et 
al. 2009), and many others.  These encompass the three main detection modalities mentioned 
above, and give just a small swath of the large spectrum of methods possible with nucleic acid 
MREs.    
 In addition to these many detection methods, MRE-based sensors have been developed 
for many different targets.  These include small molecules such as ATP as noted above, cocaine 
(Zhou et al. 2012), tetracycline (Kim et al. 2010), and many others. They also include proteins 
such as thrombin (Cho et al. 2008) and anthrax protective antigen (Cella et al. 2010), and insulin 
(Yoshida et al. 2009), among others.  It is noteworthy that many of these detection mechanisms 
are modular in that a separate MRE can be used within the same design to detect new analytes. 
 In addition to detection, nucleic acid MREs have been investigated for various 
biomedical applications.  As noted earlier, Macugen™ (pegaptanib) is in the clinic for macular 
degeneration treatment.  Other MREs have been used for in vivo therapeutic delivery of drug-
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loaded particles (Wu et al. 2010).  They can be integrated into the membrane of lipid-based 
particles, or immobilized onto the surface of certain manufactured nanoparticles, each having a 
drug-release mechanism (Yu et al. 2011; Li et al. 2012; Sundaram et al. 2012).  Furthermore, 
they have been complexed with positron emitters, fluorophores, radiolabels, or other transducing 
elements for in vivo imaging of molecular expression (Tavitian et al. 2009; Shi et al. 2010; Yu et 
al. 2011).  In spite of these applications, they have not been as widely moved into clinical 
settings as antibodies, largely due to drawbacks previously discussed.   
 In total, nucleic acid MREs have a wide array of potential applications.  They have been 
studied for their biomedical uses; however their properties allow them to be more useful in 
biosensors.  Thus, nucleic acids MREs will be the focus of molecular detection for sensing 
applications. 
1.6 Conclusions 
 Selection of MREs using differential cell SELEX represents a powerful method of 
differentiating between cell types.  This process requires no prior knowledge of cell surface 
molecule expression and takes advantage of differential expression profiles.  Peptide and 
antibody fragment libraries, the host on which the library is displayed, and the selection method 
each have advantages and situations in which they are useful.  Expansion of host scaffolds has 
been performed, even using cereal crops (Stoger et al. 2000) and human HEK-293T cells (Ho 
and Pastan 2009) to display engineered scFv molecules.  As more MREs are being developed, it 
is certain that their uses and clinical investigation will continue to expand. 
 Nucleic acid MREs have a many ideal applications, and are able to be obtained for a wide 
array of targets.  They yield a powerful method of molecular binding and differentiation of 
molecules.  As discussed, they are particularly useful in biosensors for detection of various 
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analytes.  Increasingly more detection modalities are being developed and are only limited by 
creativity of their integration.  Therefore, the continued selection and investigation of nucleic 
acid MREs is important for a variety of applications. 
 Therefore, the work discussed herein developed different types of MREs for different 
applications.  In total, the SELEX process was applied to obtaining MREs for three different 
targets.  Specifically, this work developed and utilized a novel variation called Decoy-SELEX 
which focuses on what the final MRE should not bind to.  As in classical SELEX, the library is 
enriched for the target of interest, however many stringent negative selections are performed.  
Antibody fragment MREs were obtained that could bind to prostate cancer cells and differentiate 
between them and benign prostatic cells.  These have potential in surface molecule discovery, 
cancer detection, and targeted therapy.  Separately, DNA MREs were obtained for two small 
molecule pesticides, atrazine and malathion.  These have potential use as binding molecules in 
biosensors for these environmental contaminants.  In total, each MRE has strong affinity and 
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Atrazine is a chlorotriazine herbicide used widely in crop production.  An estimated 76.5 
million pounds are used per year in the United States alone (USGS 2002).  Its use is estimated to 
increase crop yields 4-6% (Ackerman 2007).  The economic benefits of atrazine use have led to 
its continued application for many agricultural processes. 
 The widespread application of atrazine, however, leads to contamination of aquatic 
ecosystems and water supplies.  Dependent upon rainfall, up to 20% of atrazine applied to crops 
may run off or be leached from soils (Graymore M 2001).  Streams bordering croplands applying 
atrazine have been shown to be contaminated at levels up to 1000 μg/L.  Additionally, some 
drinking water reservoirs in the U.S. have up to 88.4 μg/L.  Atrazine has been detected in surface 
and ground waters in the state of West Virginia (Pasquarell and Boyer 1996; Ator and Ferrari 
1997).  Removal of atrazine in water treatment plants is possible, but varies widely throughout 
the US (Jiang H 2006).  The US Environmental Protection Agency (EPA) Maximum 
Contaminant Level (MCL) is 3 μg/L for human exposure to atrazine (USEPA 2011).  This level 
has been exceeded in many surface waters tested in West Virginia (Ferrari and Assessment 
1997).  Furthermore, the European Union has banned use of atrazine due to contamination levels 
above recommended limits (Sass and Colangelo 2006). 
 The recommended limit of exposure is based on the potential negative effects of atrazine.  
Atrazine exposure at environmentally relevant levels affects aquatic organisms; including 
feminization of male frogs (Hayes et al. 2002), salamander desiccation (Rohr and Palmer 2009), 
and endocrine disruption in fish (Suzawa and Ingraham 2008).  Endocrine disruption is also a 
potential mechanism of atrazine action in humans and other mammals (Cooper et al. 2007; Fan et 
al. 2007; Albanito et al. 2008).  It has been shown to interact with a steroidogenic transcription 
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factor and a growth factor receptor, causing signaling pathways to be upregulated.  This may 
lead to hormonally-linked cancers and reproductive abnormalities.  Additionally, atrazine may 
affect innate immune function and increase damage caused by other toxins such as arsenic 
(Tchounwou et al. 2001; Mizota and Ueda 2006).  There is, however, evidence that contradicts 
an EPA finding that atrazine is not a potential carcinogen (Mills 1998).  It is therefore important 
that food and water supplies be routinely monitored for atrazine levels. 
 The current methods of atrazine detection are either time- and labor-intensive or are not 
specific for the herbicide.  The most common method is gas chromatography, which requires 
extensive sample preparation (Amistadi et al. 1997).  Combinatory chromatographic methods 
have been used to determine the presence of atrazine in both serum and urine (Brzezicki et al. 
2003; Panuwet et al. 2008).  Antibody-based assays are also used, however the antibody used 
cannot differentiate between atrazine and closely-related molecules (Wortberg et al. 1996; Suri et 
al. 2009).  It is therefore necessary to identify an easily-synthesized binding element with high 
affinity and selectivity.  Utilizing Decoy-SELEX (Systematic Evolution of Ligands by 
Exponential Enrichment) an atrazine-specific Molecular Recognition Element (MRE) was 
identified with sub-nanomolar affinity. 
 Molecular Recognition Elements are antibody-like molecules that strongly and 
selectively bind to a target of interest.  They are produced by the in vitro selection process 
initially described independently by the laboratories of Gold and Szostak in 1990 (Ellington and 
Szostak 1990; Tuerk and Gold 1990).  MREs are selected from a large (109-1015) library of 
single-stranded DNA or RNA.  The library is initially incubated with the target of interest.  
Molecules that do not bind to the target are discarded and those that do bind are amplified.  
These are then subjected to a series of negative targets, after which molecules that do not bind 
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are amplified.  This iterative process continues, utilizing increasingly stringent conditions, until a 
MRE that specifically binds to the target of interest, but not negative targets, is identified.  The 
selected MRE may then be used for applications such as detection of the target molecule.   
A single-stranded DNA (ssDNA) MRE with high affinity and specificity for atrazine was 
isolated using a novel Decoy-SELEX process.  This SELEX variation enriches the library for the 
target of selection but focuses on stringent negative selections against undesirable binding 
targets.  Those negative targets are chosen by chemical similarities, such as target metabolites, or 
their environmental proximity to which they are found with the target.  The selection scheme for 
atrazine was designed to ensure the MRE would bind to neither atrazine metabolites diamino-
chloro-triazine (DACT) or desethyl atrazine nor the closely-related herbicide simazine (Muller et 
al. 1997).  It was also designed so that the MRE would not bind to propanil, 2,4-D acid, or 
malathion, which are pesticides found at similar levels and environments to atrazine (Kucklick 
and Bidleman 1994; Coupe et al. 2000; Purcell et al. 2001; McCarthy and Fuiman 2008).  These 
selected molecules may then be incorporated into a sensing device, allowing for specific atrazine 
detection (e.g. (Soh et al. 2009; Yang et al. 2010; Lin et al. 2011)).   
2.2 Methods 
2.2.1 Selection of Atrazine-Specific MREs 
 In order to select an atrazine-specific MRE, the Decoy- SELEX process was used (Figure 
2.1).  A single stranded DNA (ssDNA) library consisting of 1015 different molecules was 
screened through 12 rounds of selection.  The ssDNA library, termed RMW.N34, consists of two 
23 base constant priming regions for polymerase chain reaction (PCR) amplification flanking a 
34 base random region (synthesized by Eurofins MWG Operon; Huntsville, AL).  From this 
library, molecules that have a sequence and tertiary structure that specifically binds to atrazine 
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were selected.  Molecules in the library which bound to closely-related structures and other 
pesticides were removed (Figure 2.2). 
 
Figure 2.1. Scheme depicting the Decoy-SELEX process for atrazine MRE selection. A 
library of 1015 ssDNA molecules were incubated with the target atrazine.  Those that bound were 
amplified and incubated with negative targets.  Those that did not bind the negative targets were 
amplified and subjected to additional rounds of in vitro selection. 
 An atrazine derivative, desethyl atrazine (Figure 2b) (Fluka Analytical; St Louis, MO) 
was covalently biotinylated by Sulfo-NHS-LC-Biotin (Pierce; Rockford, IL) per manufacturer’s 
instructions.  Biotinylated desethyl atrazine was then incubated with streptavidin-coated 
magnetic beads (New England Biolabs; Ipswich, MA) to immobilize the selection target.  
Unbound desethyl atrazine was washed to leave only biotinylated desethyl atrazine bound to 
magnetic beads (immobilized target). 
 For positive immobilized target selection, the ssDNA library was incubated with 50 μL 
immobilized target in 500 µL of buffer consisting of 100 mM sodium chloride, 20 mM Tris-HCl, 
and 2 mM magnesium chloride (1X selection buffer; SB).  After an incubation period with 
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rotation at room temperature, the immobilized target was separated from the solution by magnet, 
washed three times with 1 mL SB, and resuspended in SB.  This suspension served as a template 
for PCR amplification of bound ssDNA.  PCR conditions were as follows: enriched ssDNA 
library, 400 nM forward and biotinylated reverse RMW.N34 primers (Eurofins MWG Operon; 
Huntsville, AL) (forward: 5’-TGTACCGTCTGAGCGATTCGTAC-3’, biotinylated reverse: 5’-
Biotin- GCACTCCTTAACACTGACTGGCT -3’), 250 µM deoxynucleotide triphosphates, 1X 
GoTaq Reaction Buffer (Promega; Madison, WI), 3.5 units Taq, and pure water.  Reaction 
conditions were: initial denaturation of 95°C for 5 minutes; cycling at 95°C for 1 minute, 63°C 
for 45 seconds, and 72°C for 1 minute; and final extension of 72°C for 7 minutes.  Large-scale 
amplification of 4 mL and 2 mL was done preceding positive and negative selection rounds, 
respectively.  This selection scheme for the desethyl atrazine target occurred for Rounds 1-5 of 
selection, each time with a shorter incubation period. 
Amplified dsDNA was then purified via the GFX PCR purification kit (GE Healthcare; 
Piscataway, NJ).  Eluted dsDNA from the column was incubated with streptavidin agarose resin 
(Pierce; Rockford, IL).  Having used a biotinylated primer for the reverse strand amplification 
allowed for binding of the amplified dsDNA to the agarose resin.  This was placed into a flow-
through column and washed with 5 volumes of 1X PBS.  Five volumes of 1 M sodium hydroxide 
were then used to dissociate the DNA strands, eluting the forward strand ssDNA from the 
column.  This solution was neutralized with 0.1 volume 3 M sodium acetate (pH 5.2), to which 
2.5 volumes of cold 100% ethanol were added.  Glycogen at 10 μg/mL was added as a co- 
precipitate for ethanol precipitation, and the solution was frozen.  After freezing, this was 
centrifuged at 13,000xg for 1 hour, washed with 70% ethanol, and centrifuged again for 15  
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Figure 2.2. Chemical structures of molecules used in the Decoy-SELEX scheme and cross-
binding assays. (a) Structure of the herbicide and target of selection atrazine. (b) Structure of 
atrazine derivative desethyl atrazine, used to immobilize onto magnetic beads.  (c) and (d) 
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Structures of simazine and diamino-chloro-triazine (DACT): chemically similar to atrazine, and 
used in rounds of negative selection. (e), (f), and (g) Structures of propanil, 2,4-D acid, and 
Malathion: pesticides found in ecologically relevant environments to atrazine and used in 
negative selections.  (h), (i), and (j) Structures of propazine, terbuthylazine, and sebuthylazine: 
structurally similar metabolites of atrazine used in cross-binding assays.  (k) Ribbon structure of 
bovine serum albumin (BSA) used in cross-binding assay (Bujacz 2012). 
 
minutes.  The supernatant was then decanted and the ssDNA pellet dried under a vacuum.  The 
purified ssDNA pellet was resuspended in SB and subjected to another selection incubation.  
 Negative selections were done to ensure the ssDNA MRE is specific for atrazine.  Sulfo-
NHS-LC-Biotin (Pierce; Rockford, IL) was blocked with Tris-HCl.  Then the blocked biotin 
reagent was incubated with streptavidin coated magnetic beads and washed with SB 
(immobilization substrate).  50 µL of blocked biotin reagent immobilized onto magnetic beads 
was incubated with purified ssDNA from the positive selection in a 100 µL volume.  After an 
incubation period, the supernatant was removed and beads were washed three times with 25, 25, 
and 50 µL SB, with removed supernatant and washes serving as a PCR template.  Amplified 
dsDNA was then prepared for another selection round as outlined above.  Negative selections 
done in this manner occurred in Rounds 1, 3, 5, and 11. 
Round 6 of selection was done as stated above, however the selection buffer consisted of 
10% methanol in 1X selection buffer (methanol selection buffer; MSB) to ensure ssDNA binding 
in ensuing selection rounds.  For Rounds 7-11 of positive selection, the purified ssDNA library 
was incubated with immobilized target as outlined above.  However, after three washes, 100 μL 
of 1 mM atrazine in MSB was incubated with the beads for decreasing time periods.  The ssDNA 
bound to the immobilized target was separated from the ssDNA in the solution phase and served 
as a template for PCR amplification.  Preparation of the library for the ensuing round of selection 
was done as noted above.   
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The Round 8 negative selection was done as described above, however ssDNA was 
competitively eluted with the pesticides propanil, 2,4-D acid, and malathion (Figure 2.2 e-g).  
The ssDNA bound to the immobilized target was separated from solution and resuspended, 
serving as the template for PCR amplification.  Rounds 9 and 10 of negative selection were done 
in the same manner, with DACT and simazine (Figure 2.2 c-d) serving as targets for competitive 
elution, respectively. 
The final round of positive selection, Round 12, was done similar to the competitive 
elutions above.  However, bound ssDNA was eluted with 100 μL of 100 μM atrazine in MSB.  
This eluted ssDNA served as a template for PCR amplification. 
2.2.2 Sequencing of Atrazine-Specific MREs 
Every third round of selection, the ssDNA library was analyzed for consensus binding 
sequences by DNA sequencing.  The PCR-amplified (using non-biotinylated primers) library 
was ligated into the pCRII vector (Invitrogen, Carlsbad, CA) and cloned into competent bacteria 
per manufacturer’s instructions.  The plasmid was then extracted using the AxyPrep Plasmid 
Prep Kit (Axygen, Union City, CA) and sent for sequencing (Eurofins MWG Operon, 
Huntsville, AL) using the M13R primer complementary to a region upstream of the PCR insert 
in the pCRII vector.  Analyses were done on 30-50 random sequences for each round to identify 
consensus sequence binding families. 
2.2.3 Atrazine MRE Binding Assays 
 From the Round 12 sequences, three sequences were chosen for further characterization.  
The predicted tertiary structures were obtained using the Mfold DNA web server at 25°C with 
buffer salt conditions (SantaLucia 1998; Peyret 2000; Zuker 2003).  R12.23, R12.28, and R12.57 
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were chosen and synthesized by Eurofins MWG Operon with an AlexaFluor 488 label for use in 
binding studies.   
Concentrations of 0, 0.25, 0.5, 0.75, 1, 5, 10, 15, 20, and 25 nM MRE were used in 
saturation binding studies.  In a 200 µL total volume of MSB, 10 uL of immobilized target was 
incubated with each concentration for five minutes.  Unbound MRE was removed and each 
incubation was washed five times with 200 µL MSB, then the immobilized target was 
resuspended in 200 µL MSB and heated to 95°C for 10 minutes to denature and elute bound 
MRE.  Eluted ssDNA in MSB was placed in a 96-well microplate and measured in a Synergy 2 
microplate reader equipped with a tungsten halogen lamp with excitation wavelength of 485 nm 
and an emission filter at 520 nm using Gen5 1.06 software (Biotek US; Winooski, VT).  All 
fluorescence readings on the plate were normalized to 100 μL of a 1 nM solution in SB of the 
fluorescent MRE and the no ssDNA incubation.  For each concentration set, the same was done 
with washed streptavidin-coated magnetic beads to ensure binding over background to the beads.  
Each set of incubations were performed in triplicate.  To determine the dissociation constant of 
R12.23, data were analyzed with Origin 8 (OriginLab Corporation; Northampton, MA) using 
nonlinear regression analysis and fit with the equation, Y=((Bmax*X)/(Kd + X)) + NS*X, where 
Bmax is the maximum binding, Kd is the dissociation constant, and NS is nonspecific binding as 
previously described (Langan et al. 2012). 
 To determine binding of the selected MRE, R12.23, to negative targets used in the 
selection, 5 nM fluorescent ssDNA was used.  For each elutant used, in a 200 µL total volume of 
MSB, 10 µL of immobilized target was incubated with R12.23 for five minutes.  The magnetic 
beads were washed five times with 200 µL MSB.  Then, each incubation was resuspended in 200 
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µL of 100 µM of the following in MSB: atrazine, desethyl atrazine, DACT, simazine, propanil, 
2-4, D Acid, malathion, and MSB only.  An incubation with no R12.23 present and  
Table 2.1. Decoy-SELEX scheme for atrazine MRE selection.   
Round  Positive Selection  Negative Selection  
1 Immobilized Target (IT) 25 hrs  Immobilization Substrate (IS) 23 hrs  
2  IT 23 hrs  -  
3  IT 18 hrs  IS 18 hrs  
4  IT 12 hrs  - 
5  IT 10 hrs  IS 16 hrs  
6  IT w/ methanol buffer 12 hrs  -  
7  IT 10 hrs, Competitive Elution 
w/ 1 mM Atrazine (CE) 5 min  
-  
8  IT 2 hrs, CE 2 min  IT 2 hrs, CE w/ propanil, 2,4-D acid 
malathion, 5  min  
9  IT 5 min, CE immediate  IT 5 min, CE w/ DACT 5 min  
10  IT 1 min, CE immediate  IT 5 min, CE w/ Simazine 5 min  
11  IT immediate, CE immediate  IS 18 hrs  
12  IT immediate, CE w/ 100 µM 
atrazine  
-  
In vitro selection process for obtaining atrazine-specific MRE.  Immobilization target (IT) is 
desethyl atrazine bound to magnet beads.  Immobilization substrate (IS) is streptavidin-coated 
magnetic beads plus blocked biotin reagent.  Competitive elution (CE) is removal of bound 
ssDNA from target-coated magnetic beads by free pesticide in solution.  Times listed are 
incubation times in hours (hrs) or minutes (min). 
with atrazine as the elutant served as normalization controls.  Each elutant was incubated with 
the immobilized target for five minutes, and the solution was removed from the beads.  This 
solution was placed in a 96-well plate and measured in a fluorescence plate reader.  Data were 
normalized to an internal fluorescent standard and then the no R12.23 control was subtracted.  
Each set of specific binding studies were performed in triplicate.  Data were averaged and 
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standard deviations calculated.  For each elutant, a t-test was performed to determine statistical 
differences in the means.  To determine binding to other molecules not used in the selection, the 
same protocol was used.  Following incubation of 5 nM fluorescent R12.23 with immobilized 
target, each incubation was eluted with 100 uM in MSB of the following: atrazine, propazine, 
terbuthylazine, sebuthylazine, and bovine serum albumin (BSA), which was used as a model of 
binding to large, globular proteins.      
2.3. Results and Discussion 
2.3.1  Selection of Atrazine-Specific MREs 
 Twelve rounds of Decoy-SELEX were completed to obtain ssDNA MREs which 
specifically bind to atrazine (Table 2.1).  The selection scheme ensured that ssDNA MREs will 
bind to atrazine in solution and neither the immobilization substrate nor malathion, propanil, 2,4-
D acid, DACT, or simazine.  PCR cycling numbers and ssDNA recovered after preparation and 
used in the ensuing selection round varied with each round of selection.  After every third round 
of selection (rounds 3, 6, 9, 12 plus after round 10), 30-50 random sequences of the ssDNA 
molecules in the library were obtained for consensus sequence family analysis.  Additionally, 
random sampling of ssDNA sequences binding to both DACT and simazine was performed.  
Consensus sequence families were analyzed and tracked throughout the Decoy-SELEX process.   
From the round 12 library, three sequences were chosen based on their inclusion in consensus 
sequence families and predicted tertiary structures.  Those sequences, R12.23, R12.28, and 
R12.57 were assayed for their binding affinity to atrazine (Figure 2.3).  Those sequences had 






Figure 2.3. Sequences and structures of atrazine MREs. The ssDNA sequence of selected 
atrazine MREs, which is above a representative consensus sequence family, with the secondary 
structure as predicted by Mfold below (SantaLucia 1998; Peyret 2000; Zuker 2003). The 
sequence and structure of (a) R12.23, (b) R12.28, and (c) R12.57.  
2.3.2 Affinity and Specificity of Atrazine-Specific MRE 
  Fluorescent saturation binding assays were performed to determine the affinity of 
R12.23, R12.28, and R12.57 for atrazine.  Concentrations of MRE in the high pM to low nM  
range were assayed, plotted, and fit by nonlinear regression analysis (Figure 2.4).  The 
equilibrium dissociation constant (Kd) of R12.23 was determined to be between 0.14 nM and 
0.97 nM (Table 2.2).  This is in the lower range of MREs targeting small molecules and 
comparable to MREs targeting proteins (Hamula et al. 2006; Stoltenburg et al. 2007).  Such high 
affinity for atrazine is likely due to the multiple rounds of selection with very stringent binding 
conditions utilizing the Decoy-SELEX process.  Fluorescent binding assays were also performed 
for R12.28, which showed a Kd between 1.28 nM and 9.20 nM, and R12.57, which showed a Kd 
between 4.42 nM and 51.74 nM.  Therefore, because of its high affinity and reproducible 
dissociation constant range, R12.23 was chosen for further binding analysis. 
 Further sequence analysis on R12.23 determined possible binding sequences.  This 
sequence had the greatest stability in the round 12 library as predicted by Mfold.  It was present 
six times in four out of eleven total large round 12 sequence families and was not evident in any 
previous round of selection.  Interestingly however, one five-base consensus sequence in R12.23 
was also found in a very large round 10 consensus sequence family (GCTTT).  Another five-base 
consensus sequence in R12.23 was found in large families in both round 6 and 9 (TGTTT).  This 
particular five-base sequence was also found as part of a consensus sequence family for ssDNA 
that bound to both DACT and simazine.  A second five-base consensus sequence in R12.23 also 
had these characteristics (GCACT).  These two sequences appeared consecutively in R12.23, and 
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were part of a large dual-hairpin in the predicted structure (Figure 2.3a).  This therefore suggests 
that while this full MRE sequence did not appear in any prior rounds' random sequencing efforts, 
components therein were important in binding to atrazine and surviving the Decoy-SELEX 
process while others were important in conferring specificity.        
 
Figure 2.4. Fluorescent equilibrium binding assay of R12.23. Representative saturation 
binding assay  with nonlinear regression best fit.  Kd R12.23 for atrazine in this data is 0.75 nM 
+/- 0.22 nM. 
Table 2.2.  Equilibrium dissociation constant (Kd) of atrazine MREs. 
Plot R12.23 R12.28 R12.57 R12.23.TRNC1 
1 0.75 +/- 0.22 nM 1.28 +/- 0.85 nM 51.74 +/- 7.75 nM 0.079 +/- 0.065 nM 
2 0.14 +/- 0.04 nM 9.20 +/- 3.02 nM 6.18 +/- 8.67 nM 0.700 +/- 0.777 nM 
3 0.97 +/- 0.61 nM 4.81 +/- 1.75 nM 4.42 +/- 3.67 nM 0.848 +/- 0.826 nM 




Figure 2.5. Sequence and structure of R12.23.TRNC1. (a) Designed sequence of 
R12.23.TRNC1. (b) Secondary structure of R12.23.TRNC1 as predicted by Mfold. 
 To further determine the binding site of R12.23 and in an effort to increase binding 
affinity, a truncated sequence was designed and termed R12.23.TRNC1 (Figure 2.5).  It is 
comprised of a 34 base sequence which composes the major dual hairpin-loop structural 
component of the full-length R12.23 discussed in the previous paragraph (Figure 2.5) 
(synthesized by Katherine Hickey and Peter Gannett of WVU Basic Pharmaceutical Sciences).  
Fluorescent saturation binding assays using a fluorescein-labeled MRE were performed with this 





nM (Table 2.2) (data generated by Eamonn Maher and Ginger He of the Sooter Lab).  The 
affinity of the truncated sequence is overall as good as or better than the full-length sequence.  
This is similar to previous work that has assayed binding affinity of truncated MRE sequences 
(Kaur and Yung 2012).  Therefore, it is likely that this is the binding domain of R12.23.  
 
Figure 2.6. Cross-binding studies of R12.23 atrazine MRE to other molecules. Data were 
normalized to atrazine binding which was set to 100%, with error bars representing standard 
deviations.  Statistical significance levels of p<0.05 are designated by ‘*’, while levels of p<0.01 
are designated by ‘**’ (a) Atrazine is the target of selection, desethyl atrazine is the derivitave 
used for immobilization to magnetic beads.  DACT and simazine are metabolites of atrazine. 
Propanil, 2-4, D acid, and malathion are pesticides found in close environmental proximity to 
atrazine. (b) Propazine, terbuthylazine, and sebuthylazine have closely-related chemical 
structures, but were not used in the selection scheme.  Bovine serum albumin (BSA) readily 
binds many molecules and was used as a model of the MRE binding to proteins. 
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 Fluorescent specificity binding assays were also performed on the atrazine MRE using 
elution from immobilized target beads.  Analysis showed significantly higher binding of R12.23 
to atrazine in solution than to four of the five negative targets used in the selection (Figure 2.6a).  
These included DACT, simazine, propanil, and 2-4,D Acid (Figure 2.2).  Binding to malathion in 
solution did occur but was highly variable.  This may be because malathion is known to be 
reactive toward DNA by cleaving the strand (Pluth et al. 1996; Reus et al. 2008; Moore et al. 
2010).  This reactivity of malathion may not affect signal of a field- deployable sensor if it is 
designed to function based on MRE folding and not cleavage.  It is important to note that R12.23 
is selective for atrazine over simazine, as current molecular recognition elements for atrazine are 
not (Wortberg et al. 1996).  Also, the MRE has no affinity for desethyl atrazine in solution.  This 
is noteworthy because this atrazine derivative was immobilized on magnetic beads and used for 
the initial positive rounds of selection.  Additionally, even though binding to atrazine is 
approximately two-fold higher than it is to DACT or simazine, the dissociation constant may be 
much higher than twice that of R12.23 for atrazine.  Therefore, incorporation into a sensor may 
lead to much greater specificity than it appears here.  It is clear that stringent competitive 
elutions selected for an MRE that has high specificity for atrazine in solution compared to the 
negative targets.   
 Interestingly, structurally similar molecules (Figure 2.2) which were not used as negative 
targets bound to the selected MRE (Figure 2.6b).  This may be due to the structural complexity 
of the MRE.  Binding is statistically as strong to propazine, terbuthylazine, and sebuthylazine.   
This suggests that R12.23 requires the chlorotriazine base, as do antibodies that bind to atrazine 
(Herranz et al. 2008).  It also suggests that it requires a certain level of complexity on the amine-
linked side-groups of the chlorotriazine base.  Based on the structures, it seems binding requires 
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at least four total carbons in the side-groups.  As simazine also meets this requirement, it seems a 
second requirement is having at least one side-group with three carbons.   This is evidenced by 
the lack of binding to simazine, DACT, and desethyl atrazine, which do not meet these 
complexity requirements.  Propazine, with two amine-linked isopropyl groups, terbuthylazine, 
with an amine-linked ethyl and an amine-linked tert-butyl, and sebuthylazine, with an amine-
linked sec-butyl, exceed these complexity requirements.  It is unclear how more complex 
chlorotriazines would be bound by the MRE.  Exceedingly-complex chlorotriazines, however, 
likely would be too large to fit in the MRE binding pocket.  Bovine serum albumin (BSA) was 
used as an example of potential MRE binding to proteins.  The MRE did not show significant 
binding to BSA.  It is likely that, in spite of some cross-reactivity to more complex 
chlorotriazines, R12.23 will be useful in a sensor for a class of molecules.  After rapid, field-
based detection with the MRE, more rigorous analytical approaches such as gas chromatography 
can be used to identify all present contaminants.    
     The high affinity and specificity of the atrazine MRE are both important characteristics 
for its further use in detection applications, such as contaminated ecosystems or individuals.  
Nucleic acid MREs have previously been developed and used in environmental biosensing for 
small molecules (Strehlitz et al. 2012; Yildirim et al. 2012).  They have also been used for 
detection of analytes in serum (Soh et al. 2009).  In both contexts, it is necessary for the MRE to 
differentiate between the target and closely-related molecules or other contaminants.  The novel 
selection method reported herein is capable of generating such MREs.  Once atrazine-polluted 
environments or contaminated at-risk individuals are identified, they can be actively remediated 
or treated with chemical, physical or biological methods (Mandelbaum et al. 1995; Saltmiras and 




 A novel variation of the SELEX process, called Decoy-SELEX, is presented to select a 
molecular recognition element with high affinity and specificity for the herbicide atrazine.  The 
MRE binds with a sub-nanomolar equilibrium dissociation constant and is selective for atrazine 
over several metabolites and other pesticides.  The results validate the Decoy-SELEX process 
while identifying a new mechanism for atrazine detection in environmental and biological 
mediums.   This work will improve upon current analysis of atrazine contamination and allow for 







































































 Carbon nanotubes are cylindrical fullerenes that can be visualized as rolled graphene 
sheets with walls of single atom thickness. Their discovery stemmed from the discovery of 
buckminsterfullerene in 1985 (Kroto et al. 1985).  Sumio Iijima originally described multi-wall 
carbon nanotubes (MWCNT) in 1991 (Iijima 1991; Ajayan 1999).  Single-wall carbon nanotubes 
(SWCNT) were independently described by Iijima and Ichihashi as well as an IBM team in 1993 
(Bethune et al. 1993; Iijima and Ichihashi 1993).  Since this time, research into their production, 
properties, and applications has increased. 
 In those original investigations by Iijima the carbon nanotubes were produced by the arc-
discharge method.  MWCNT were discovered as a deposit on the graphite cathode tip of this 
chamber (Iijima 1991; Ando and Zhao 2006).  In contrast, SWCNT were discovered as a soot 
from the gas phase of an arc-discharge chamber using either an iron or cobalt catalyst (Bethune 
et al. 1993; Iijima and Ichihashi 1993; Ando and Zhao 2006).  Characterization and confirmation 
of the products was performed using transmission electron microscopy and electron diffraction. 
There have since been new production and characterization methods but these remain useful in 
the field. 
 Physical differences between MWCNT and SWCNT confer unique properties.  The 
diameter of an individual SWCNT is typically in a narrow range between 0.5 and 2 nm, while 
that of a MWCNT is 2-25 nm (Ajayan et al. 1999).  This is because SWCNT have walls only one 
atom thick, while MWCNT have concentric walls approximately 0.34 nm apart (Ajayan 1999).  
Both, however, have a high aspect ratio, with individual tubes typically having lengths in the 
micron range.  Due to variations in how the edges of graphene sheet meet, walls of both carbon 
nanotube forms may have helicity, which plays a large role in their physical properties.  The 
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walls of MWCNT may have different helicity, and therefore less uniform with less ideal optical 
and electronic properties for individual tubes (Ajayan 1999).  Individual SWCNT species, 
however, have uniform and characteristic properties which give them greater potential for 
application.  The helicity of a SWCNT species is also referred to as its chirality, or its (n,m) 
species (Figure 3.1).  This designation derives from the angle at which the tube is rolled.  Achiral 
carbon nanotubes are either in the armchair (n,n) or zigzag (n,0) conformations.  Some properties 
have been investigated, however there is much yet to be determined.   
 
Figure 3.1. Derivation of SWCNT (n,m) chiral species. A visual representation of a graphene 
sheet depicts the derivation of SWCNT chirality.  Carbon bonds form hexagons, and SWCNT 
can be visualized as rolled-up graphene sheets.  The angle at which the sheet is rolled determines 
the chirality, or the (n,m) designation of the tube.  Some n,m species are shown here, with the 
lines from which zigzag and armchair chiral species are derived.  Image is derived from 
previously-published depiction (Weisman 2010). 
 
 The potential application of SWCNT has led to an increase in their production and use.  
There has been a push to determine their interaction with biological materials.  This is because 
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they have enormous potential in biological sensors and medical treatments.  It is also true, 
however, because there will be an increase in environmental contamination by these particles.  It 
is therefore necessary to understand the production of SWCNT, their special properties, and the 
applications of SWCNT. 
3.2 SWCNT Production 
 The initial synthesis of SWCNT by the arc-discharge method with a catalyst is still one of 
the three major forms of their industrial synthesis.  Synthesis by laser-ablation and chemical 
vapor deposition for catalytic growth has since been adopted. 
3.2.1 Arc-Discharge Method 
 The arc-discharge method of SWCNT product was the first developed and remains to be 
in use because it is simple and has a relatively high yield (Baddour and Briens 2005). To produce 
SWCNT, a chamber is filled with an inert gas and contains two graphite electrodes (Bethune et 
al. 1993; Iijima and Ichihashi 1993).  A metallic catalyst such as iron or cobalt is placed on either 
of the electrodes.  Then a direct current is applied between the electrodes and SWCNT are 
deposited from the vapor phase of the chamber.  The resulting SWCNT products are relatively 
short, bundled, and need purification due to impurities (Saifuddin et al. 2013).  This method was 
scaled-up from initial production in 1997 by the work of Journet et al. (Journet et al. 1997), 
however larger-scale production remains difficult.   
3.2.2 Laser-Ablation Method 
 Laser-ablation synthesis of SWCNT is the most expensive method of SWCNT 
production, however the product is of relatively high purity (Baddour and Briens 2005).  A target 
of graphite with metal catalysts is inserted into a furnace with an inert gas in this method (Guo et 
al. 1995; Thess et al. 1996).  High-intensity laser pulses are then directed at the graphite and 
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SWCNT are deposited on a water-cooled collector (Popov 2004).  This method is only useful for 
production of SWCNT and not MWCNT.  Additionally, it can be more finely tuned by laser and 
gas properties to produce SWCNT with specific characteristics (Saifuddin et al. 2013).  
However, the product is tangled and needs purification.  This coupled with the high cost makes 
this method is not as extensively used as the other two. 
3.2.3 Chemical Vapor Deposition Method 
 Synthesis of SWCNT by chemical vapor deposition (CVD) is the most inexpensive and 
easiest method to scale up for industrial purposes.  This method involves the production of 
SWCNT by flowing hydrocarbons and an inert gas over a metal catalyst in a furnace (Popov 
2004).  It was initially used for production of carbon filaments before the discovery of SWCNT 
(Baker 1989).  Since then, however, it has been adapted and scaled up for industrial carbon 
nanotube production (Joseyacaman et al. 1993; Amelinckx et al. 1994; Ivanov et al. 1994; Li et 
al. 1996).  This process generally favors the production of MWCNTs, however the 
characteristics of SWCNT are highly controllable under specific conditions (Kong et al. 1998; 
Baddour and Briens 2005; Saifuddin et al. 2013).  Overall, the CVD method typically has high 
purity and produces longer nanotubes.  The only drawback to this method is that the SWCNT 
typically have many defects (Saifuddin et al. 2013).  Despite this, the simplicity, cost-
effectiveness, and scalability of the CVD method make it the most widely-used for industrial 
purposes. 
3.2.4 Purification and Enrichment 
 After synthesis of SWCNT, they may undergo multiple processes before their study and 
application.  These include purification of the nanotubes from synthesis contaminants and 
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enrichment of particular SWCNT types.  Both of these steps may affect the SWCNT properties 
and neither of them is completely optimized.   
 Purification of SWCNT is necessary after the synthetic process due to carbonaceous and 
catalytic metal impurities.  The most commonly-used methods for this are oxidation, filtration 
and chromatography, chemical functionalization, and microwave heating (Haddon et al. 2004; 
Park et al. 2006).  There are, however, other techniques that may be used in conjunction with 
these, such as centrifugation, ultrasonication, and magnetic separation (Saifuddin et al. 2013).   
 Another possible form of post-synthetic processing is enriching SWCNT of a particular 
diameter, length, or chirality  It is important to be able to do this because these characteristics are 
strong determinants of SWCNT physical properties (Zhang and Zheng 2010).  This may be 
partially done through controlled synthesis with specific temperatures, catalysts, or substrates 
(Bandow et al. 1998; Kukovitsky et al. 2002).  However, it is also possible to enrich particular 
SWCNT types by oxidation and etching (Zhang et al. 2006; Miyata et al. 2007).  Enrichment of 
SWCNT by chirality and diameter is possible through ultracentrifugation (Arnold et al. 2006).  
Finally, the affinity of particular surfactants for individual (n,m) species has been used to 
separate SWCNT (Ju et al. 2008; Marquis et al. 2008).  Of these, DNA is the most promising, as 
individual sequences have greater affinity for particular diameters and chiralities (Huang et al. 
2005; Albertorio et al. 2009; Tu et al. 2009; Tu et al. 2011).  Obtaining pure SWCNT chiral 
species is important for many applications, however the process remains difficult to obtain 
highly pure samples (Komatsu and Wang 2010; Zhang and Zheng 2010).  
3.3 Properties of SWCNT 
 Single-wall carbon nanotubes have many properties that make them ideal for a range of 
applications (Table 3.1).  These include special mechanical, electrical, and optical characteristics.  
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As mentioned previously, the properties depend strongly on the SWCNT diameter, chirality, and 
length.   
Table 3.1. Special properties of single-wall carbon nanotubes (SWCNT) and their 
correlation to applications. 
Property Description Application 
Mechanical -Very strong  
-High stiffness  
-Flexible 
-Large surface area 
-Low density 
-Replacement of carbon 
fibers for material 
reinforcement 
-Polymer integration for 
flexibility and strength 
Electrical -Individual chiralities are 
either metallic or 
semiconducting 
-Conductors in electronics 
-Signal transducers in 
sensors 
 
Optical -Fluorescence in the near-
infrared region 
-Exact fluorescence 
properties dependent on 
chirality and length 
-Optical fluorescence 
sensors 
-In vivo imaging 
-Chirality, length, and 
dispersion characterization 
Functionalization -Ability to be chemically 
modified 
-Ability to be wrapped or 
adsorbed to by biological 
molecules 




3.3.1 Mechanical Properties 
 The mechanical properties of SWCNT have made them of high interest for many 
industrial applications.  They are considered very strong with high stiffness due to characteristic 
sp2 carbon bonding (Robertson et al. 1992; Popov 2004).  Individual SWCNT have an average 
Young's modulus value of 1.8 TPa, which is an extraordinarily large measure of stiffness for a 
material (Jacobsen et al. 1995).  Important for engineering and industrial purposes, the value for 
bundled SWCNT is estimated to be 600 GPa; lower due to weaker associations and formations 
of individual tubes (Salvetat et al. 1999).  This, however, can theoretically be up to 38 TPa for 
identical achiral SWCNT, which could be extremely useful in engineering applications (Popov et 
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al. 2000).  They are unique in that they also have a high flexibility in spite of their strength and 
stiffness (Coleman et al. 2006).  Additionally, SWCNT have a very high surface area and a 
relatively low density of 0.6 g/cm3 (Ajayan 1999).   
3.3.2 Electrical Properties 
 Single-wall carbon nanotubes may be metallic or semiconducting based on their chirality.  
Of all possible SWCNT species, 33% are metallic and 67% are semiconducting (Saito et al. 
1992; Zhang and Zheng 2010), with all armchair conformations being metallic and zigzag and 
chiral being either (Ajayan 1999).  These properties make it possible to use individual species or 
broad classes of SWCNT in electronics or sensors.  Additionally, it is possible to use nanotubes 
to create intramolecular electronic junctions (Ouyang et al. 2002).  Overall, the electronic 
properties of SWCNT have been studied largely by scanning tunneling microscopy (STM) 
(Ouyang et al. 2002).  Due to these properties, SWCNT have a great deal of potential in 
electronic and sensing applications. 
3.3.3 Optical Properties 
 The specialized optical properties of SWCNT make them particularly important for 
sensing and biomedical applications.  Semiconducting nanotubes have optical absorption peaks 
corresponding to excitation of electrons from valence to conduction bands, a separation referred 
to as the band gap (Weisman 2010).  These well-defined peaks are referred to as E11, E22, and so 
on, which fall in the near-infrared (IR) and visible light regions, respectively.  Fluorescence has 
been observed across the near-IR band gap of SWCNT (O'Connell et al. 2002).  As this is highly 
dependent on the diameter and chirality of the SWCNT, it is possible to characterize the 
nanotubes present in a sample based on its optical properties (Bachilo et al. 2002).  Furthermore, 
the near-IR region is relatively unabsorbed by tissue, thus making SWCNT of great potential for 
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biological imaging and therapeutics (Welsher et al. 2011).  SWCNT can generate and detect light 
while functioning as a transistor, and therefore have great potential for combined electronic and 
optical devices (Avouris et al. 2008).  It is also possible to use absorbance versus fluorescence as 
a relative measurement of SWCNT dispersion in solution.  This is because bundled SWCNT 
absorb light, but their fluorescence output is dampened (Weisman 2010).  It is therefore obvious 
that optical characterization and applications of SWCNT have great potential. 
3.4 SWCNT Applications 
 Stemming from these properties of SWCNT is the ability to use them in a variety of 
applications (Table 3.1).  They have been integrated into industrial, electronic, sensing, and 
biomedical processes, among others.  It is also important to note that for many applications, it is 
necessary to have pure or enriched SWCNT species in order to have uniform properties. 
3.4.1 Industrial Applications 
 Due to their unique mechanical properties, SWCNT have been incorporated into 
polymers to form composites with desirable properties (Breuer and Sundararaj 2004).  They are 
often used instead of carbon fibers, which are used to reinforce and enhance materials for 
aerospace, automotive, or sporting and protective equipment.  They can also be integrated into 
composites for their ability to dissipate electrostatic interactions, which can be important in safer 
materials.  Considerable research has gone into optimizing the interface of SWCNT and 
polymers to extract ideal properties (Thostenson et al. 2001).  This work has significantly 
increased the stiffness of composite materials  and led to an increase of SWCNT-related products 





3.4.2 Electronic Applications 
 The application of SWCNT in electronics has also become more widespread.  This is 
because of their excellent conductivity, surface area, and ability to take different macroscopic 
shapes (Schnorr and Swager 2011).  SWCNT have thus been studied for use in lithium ion 
batteries and transparent electrodes, which are components of organic solar cells and organic 
light-emitting diodes (OLEDs) (Ng et al. 2005; Kim et al. 2009; Landi et al. 2009; Chien et al. 
2010).  Additionally, they can be used as capacitors and even to build smaller and more efficient 
electronic circuits, among many other uses (Franklin et al. 2001; Baughman et al. 2002; Du and 
Pan 2006; Schnorr and Swager 2011).   
3.4.3 SWCNT in Sensors 
 The use of SWCNT in sensors can be closely related to their electronic applications.  
However, SWCNT-based sensors may also rely on their optical properties.  An example of an 
electronic-based SWCNT sensor is a field effect transistor (FET) (Tans et al. 1998).  The 
nanotubes can adsorb, be wrapped by, or covalently bound to sensing molecules, which changes 
the conductance of the nanotube upon binding (Pengfei et al. 2003; So et al. 2008; Schnorr and 
Swager 2011).  They have also been used for detection of gases and chemical vapors through 
chemically reactive coatings (Novak et al. 2003; Snow et al. 2005).  As mentioned above, 
polymers or other biological sensing molecules can be attached to SWCNT.  This includes 
adsorption or the covalent attachment of antibodies as well as covalent attachment or wrapping 
of DNA around nanotubes (Zhang et al. 2009).  These can function in sensors as described 
above, or can be part of optical SWCNT sensors (Huang et al. 2011).  An important example of 
this is the near-infrared detection of analytes with DNA and DNA molecular recognition 
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element(MRE)-wrapped SWCNT (Jeng et al. 2006; Chen et al. 2009).  These are among many 
other examples of research being done to develop SWCNT-based sensors. 
3.4.4 Biomedical Applications 
 One area of great potential for SWCNT use is in biomedical applications, which draws on 
multiple properties of this material.  An important necessity of this use is that the nanotubes are 
not toxic to humans.  Multiple studies have shown that SWCNT functionalized or non-covalently 
altered with biological molecules reduce their toxic effects (Vardharajula et al. 2012).  Therefore, 
they have been developed for use as in vitro and in vivo imaging tools, as their near-infrared 
fluorescence is detectable through cells and tissue (Welsher et al. 2011; Kang et al. 2012).  
Additionally, they have been used to deliver small molecule and biologic drugs as well as genes 
to specific diseases (Pantarotto et al. 2004; Portney and Ozkan 2006; Bhirde et al. 2010).  
Research is ongoing to ensure the safety of SWCNT in biomedical applications, which will lead 
to an invaluable tool for clinical diagnostics and therapeutics. 
3.5 Conclusions 
 Single-wall carbon nanotubes are an extraordinary and relatively new class of materials 
into which research is ongoing and increasing constantly.  This is due to their unique and 
desirable properties, which are drawn from their production, purification, and enrichment.  They 
have particular value in both biomolecular sensing and biomedical applications.  Both of these 
uses require further work into understanding the interactions of SWCNT and biological 
molecules and systems.   
 The work described here was completed to further determine specific properties of 
SWCNT.  As noted, their interaction with DNA is of particular interest for sorting and 
separation, sensors, and other applications.  The effect of multiple chiralities of DNA wrapped 
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with different DNA sequences on the polymerase chain reaction was determined.  This will 
allow for future work in separation of SWCNT and in sensors.  Additionally, the effect of 
SWCNT on a green algae model organism was determined.  This will help to determine future 
environmental impacts of widespread DNA-wrapped SWCNT use and whether these constructs 
are safe for use.  Together, these investigations into the interactions of biological systems and 
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  Single-wall carbon nanotubes (SWCNT) are cylindrical fullerenes with walls of single 
carbon atom thickness (Iijima 1991; Iijima and Ichihashi 1993; Ajayan 1999).  They have 
enormous potential in industrial, sensing, and biomedical applications due to their unique 
physical, electronic, and optical properties (Heller et al. 2005; Wang 2005; Coleman et al. 2006; 
Huang et al. 2011).  SWCNT may be either metallic or semiconducting, with 33% and 67%, 
respectively, of all potential species having those characteristics (Saito et al. 1992; Zhang and 
Zheng 2010).  The unique properties of SWCNT are dependent upon the chirality and diameter 
of the SWCNT, however purification of individual species remains difficult (Zhang and Zheng 
2010).  Individual types of semiconducting SWCNT have unique optical fluorescence properties 
(O'Connell et al. 2002).  Therefore, in applying SWCNT, it is possible to take advantage of their 
electrical or optical properties, separately or combined (Avouris et al. 2008).        
 Single-stranded DNA has been used to disperse hydrophobic SWCNT in solution (Zheng 
et al. 2003).  The interaction of DNA sequences with SWCNT may have implications in sensing 
and purification techniques.  Individual sequences have been identified that preferentially wrap 
certain SWCNT chiralities (Huang et al. 2005; Albertorio et al. 2009; Tu et al. 2009; Tu et al. 
2011).  DNA-associated SWCNT have also been used in molecular sensing (So et al. 2005; Jeng 
et al. 2006; So et al. 2008).  The potential use of a DNA-wrapped SWCNT (DNA:SWCNT) 
platform shows promise  in multiple applications; however research is continuing to optimize use 
of these complexes. 
 In sensing applications and analysis of environmental samples, it is useful to employ 
polymerase chain reaction (PCR) techniques in order to exponentially amplify the SWCNT-
associated DNA sequence.  Additionally, there has been work to develop PCR-based 
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microfluidic sensing devices (Khandurina et al. 2000), as well as DNA-functionalized SWCNT 
sensing devices (So et al. 2005).  Integration of these two sets of technologies would create new 
potential analyte detection mechanisms.  Therefore, it is important to determine the effect of 
DNA-associated SWCNT on the polymerase chain reaction.     
The aim of this study was to investigate amplification of DNA by the polymerase chain 
reaction (PCR) in the presence of DNA-dispersed SWCNT.  Factors investigated include DNA 
sequence-dependence, SWCNT chirality-dependence, and DNA:SWCNT concentration-
dependence; amplification of the wrapping sequence itself; and age of the DNA-SWCNT 
preparation.  This work will provide a basis for further DNA-dispersed SWCNT studies which 
require PCR amplification.   
4.2 Methods 
4.2.1  DNA-Dispersed SWCNT Preparation 
 DNA:SWCNT preparations were made similarly to previously described methods (Zheng et al. 
2003; Lahiji et al. 2007).  Briefly, 2 mg CoMoCAT SWCNT were mixed with 2 mg DNA in 2 mL 
phosphate-buffered saline (PBS).  SWCNT used were: without chiral purification “Mix” or (6,5) 
chirality-enriched (Sigma-Aldrich; St. Louis, MO).  DNA sequences used were: estradiol (E2) Molecular 
Recognition Element (MRE) (Table 4.1) (Kim et al. 2007), TG15 (Table 4.1) (Eurofins MWG Operon; 
Huntsville, AL), or salmon testes genomic DNA (Sigma-Aldrich; St. Louis, MO).  This mixture was 
sonicated on ice for two hours with a Virsonic XL2020 ultrasonic liquid processor (Misonix; 
Farmingdale, NY) equipped with a 3.2 mm microtip at approximately 20% power.  The resulting solution 
was centrifuged at 16,000xg for 90 minutes to remove insoluble SWCNT.  The solution was then filtered 
through an Amicon Ultra-4 Centifugal Filter unit with 100,000 molecular weight filter (Millipore; 
Billerica, MA) three times at 4000 RPM for 15 minutes each to remove DNA that did not associate with 
the SWCNTs.  The recovered DNA:SWCNT solution was brought to a volume of 500 µL with  PBS.  The 
concentration of the DNA:SWCNT sample was obtained by gravimetric analysis of 10 µL of the solution 
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weighed on an Ohaus Discovery Microbalance (Ohaus; Parsippany, NJ).  Samples were stored in screw-
top containers at room temperature before use.  To determine the effect of DNA:SWCNT preparation age 
on PCR, samples were used that were prepared between four and ten months before assayed or less than 
one month before assayed.  In total, 12 DNA:SWCNT samples were prepared. 
Table 4.1.  Synthesized DNA sequences used in DNA:SWCNT PCRs. 









4.2.2  SWCNT Characterization 
 Absorption and near-infrared (NIR) fluorescence measurements were performed as previously 
described with few modifications (Weisman 2010).  Briefly, each DNA:SWCNT preparation was diluted 
to a 1% solution with distilled-deionized water (Millipore; Billerica, MA).  This solution was added to a 
10 mm path length cuvette (Starna Cells; Atascadero, CA) and analyzed on a NanoSpectralyzer 1 (NS1) 
(Applied NanoFluorescence; Houston, TX).  The absorbance spectrum was collected from 400 - 1600 nm.  
Additionally, fluorescent emission spectra were measured using excitation wavelengths of 638 nm, 690 
nm, and 784 nm.  The resulting spectra were analyzed with ANFSoft (Applied NanoFluorescence; 
Houston, TX).  Fluorescence efficiency measurements, which are fluorescence intensity (RFU) collected 
across the emission spectrum for a single wavelength divided by the absorbance spectrum, are reported as 
a relative measure of SWCNT dispersion in solution. 
4.2.3 Polymerase Chain Reaction in the Presence of DNA-Dispersed SWCNT 
 
 In total, 16 sets of PCR experiments were performed involving 7 individual PCR reactions per 
set.  PCR reactions were composed of: 60 nM E2 MRE, 400 nM forward and reverse E2 MRE primers 
(F.E2 and R.E2)  (Table 4.1), 250 µM deoxyribonucleotide triphosphates, 1X GoTaq Reaction Buffer 
(Promega; Madison, WI), 3.5 units Taq DNA Polymerase, DNA:SWCNT suspension, and Milli-Q water 
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to 50 µL.  DNA:SWCNT were added to final concentrations of: 0.01 mg/mL, 0.1 mg/mL, 1 mg/mL, 5 
mg/mL, 10 mg/mL.  For each set, a negative control was performed with no E2 MRE or DNA:SWCNT 
and a positive control was performed with no DNA:SWCNT added.  Reactions were performed on an MJ 
Mini Thermal Cycler (Bio-Rad; Hercules, CA) with conditions: initial denaturation of 95°C for 5 
minutes; 20 cycles of 95°C for 1 minute 30 seconds, 68°C for 45 seconds, and 72°C for 1 minute 30 
seconds; and final extension of 72°C for 7 minutes.  Amplification of DNA directly associated with 
SWCNT was performed using E2 MRE:SWCNT preparation with no additional E2 MRE added to the 
reaction mix.    
4.2.4 PCR Analysis by Agarose Gel Electrophoresis 
 Each set of control and DNA:SWCNT PCRs  was run on a 4% agarose gel for 30 minutes 
at 135 volts in 1X Tris:Borate:EDTA buffer.  Five µL of each PCR and 3 µL of 100bp and 25bp 
ladder (Promega), were mixed with 2 µL 6X loading dye (Promega) prior to loading in the well.  
Gels were pre-stained with 5 µg/mL ethidium bromide and imaged with UV illumination on a 
BioRad Gel Doc System and analyzed on Quantity One Software (Bio-Rad; Hercules, CA).   
4.3 Results and Discussion 
4.3.1 Analysis of DNA:SWCNT Preparations 
 All DNA:SWCNT samples were analyzed by absorbance and NIR fluorescence 
spectroscopy to determine their SWCNT chirality composition and dispersion in solution 
(singly-dispersed SWCNTs) (Figures 4.1 and 4.2).  DNA:SWCNT samples greater than four 
months old were more well-dispersed than the identical DNA:SWCNT preparation of less than 
one month.  This would suggest that dispersion of SWCNT in solution with DNA increases with 
time.  Additionally, for both old and new samples, TG15 and E2 MRE dispersed the (6,5)-
enriched SWCNT better than mixed chirality SWCNT (Figures 4.1 and 4.2, fluorescence 
efficiency). These results are consistent with previously published results that have shown short, 
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synthetic DNA sequences rich in thymine and guanine have a high affinity for (6,5) chiral 
SWCNTs (Kim et al. 2008). Conversely, the salmon testes genomic DNA:Mix SWCNT samples 
were more well-dispersed than Salmon testes genomic DNA:(6,5) SWCNT. These results 
suggest that although the genomic DNA shows the highest association with (6,5)-chiral 
SWCNTs (Figures 4.1 and 4.2, topography plots) it also forms stable associations with other 
chiralities.    
4.3.2 Agarose Gel Analysis of Old DNA:SWCNT PCRs 
 Agarose gel analysis of PCRs performed with increasing concentrations of 
DNA:SWCNT preparations between four and ten months old suggest that accurate amplification 
products of 76 base pairs (bp) can be obtain at concentrations of 0.1 mg/mL and below for all 
preparations (Figure 4.1 agarose gels).  In most cases, efficiency of PCR amplification is either 
unaffected or slightly aided at 0.01 and 0.1 mg/mL compared to the positive control reaction 
(Figure 4.1 relative intensities).  The exception to this is the TG15:(6,5) sample (Figure 4.1b), 
where a very faint band is produced at 0.1 mg/mL.  Additionally, bands are produced at 1 mg/mL 
for TG15:Mix and E2:(6,5) PCRs.  No distinct bands are produced at 5 or 10 mg/mL 
concentration PCRs for any preparation.  Prior work has shown that SWCNT sonicated in water 
just before being added to a PCR reaction increased amplification efficiency of a 410 bp product 
at concentrations up to 3 mg/mL (Cui et al. 2004).  The same study showed that SWCNT in a 
PCR reaction interacts with both the DNA template as well as Taq DNA Polymerase.  This 
study, however, has DNA wrapped around SWCNT, so this is unlikely to be the source of 
inhibition.  Another study showed that that SWCNT functionalized with carboxylic groups 
produce stronger interactions with Taq and more inhibition of PCR than did pristine SWCNT at 




Figure 4.1. (a-d). Agarose gel electrophoresis images and analysis of PCRs with old (4-10 months) 
DNA:SWCNT samples. For each set, top left is agarose gel image with lanes and quantitized boxes 
shown, top center is intensity line graph, top right is NS1 synthesized fluorescence intensity plot of 
DNA:SWCNT samples (y-axis is excitation wavelength, x-axis is emission wavelength), bottom left is 
bar graph of relative intensity within boxes on gel (normalized to 100 bp marker of 25 bp ladder), bottom 
center is fluorescence efficiency at each wavelength in NS1 analysis (higher numbers correlate with 
greater dispersion).  Lanes in agarose gel images and relative intensity bar graph: 1. 25 bp ladder (black) 
2. empty (dark blue) 3.  negative control (red) 4. positive control (green) 5. 0.01 mg/mL DNA:SWCNT 
(purple) 6. 0.1 mg/mL (neon blue) 7. 1 mg/mL (orange) 8. 5 mg/mL (light blue) 9. 10 mg/mL (pink)10. 
100 bp ladder (black).  Intensity line graph colors correlate with bar graph colors in relative intensity 















Figure 4.1. (e-h). Agarose gel electrophoresis images and analysis of PCRs with old (4-10 months) 
DNA:SWCNT samples. For each set, top left is agarose gel image with lanes and quantitized boxes 
shown, top center is intensity line graph, top right is NS1 synthesized fluorescence intensity plot of 
DNA:SWCNT samples (y-axis is excitation wavelength, x-axis is emission wavelength), bottom left is 
bar graph of relative intensity within boxes on gel (normalized to 100 bp marker of 25 bp ladder), bottom 
center is fluorescence efficiency at each wavelength in NS1 analysis (higher numbers correlate with 
greater dispersion).  Lanes in agarose gel images and relative intensity bar graph: 1. 25 bp ladder (black) 
2. empty (dark blue) 3.  negative control (red) 4. positive control (green) 5. 0.01 mg/mL DNA:SWCNT 
(purple) 6. 0.1 mg/mL (neon blue) 7. 1 mg/mL (orange) 8. 5 mg/mL (light blue) 9. 10 mg/mL (pink)10. 
100 bp ladder (black).  Intensity line graph colors correlate with bar graph colors in relative intensity 














DNA:SWCNT and Taq, but it is unlikely to be as strong of an interaction and inhibitory effect as 
with carboxylic SWCNT.      
 It is also possible to PCR amplify E2 MRE target which is only present in the reaction 
wrapped around SWCNT (Figure 4.1g and h).  These concentration-dependence patterns follow  
a similar pattern to reactions performed with the addition of free E2 MRE.  This is important in 
that it shows the ability to directly amplify DNA which is associated with SWCNT. 
 It is also clear that addition of DNA:SWCNT to PCR reactions has effects on amplicons 
produced.  In both Salmon:SWCNT samples (Figure 4.1c and d intensities), smears are visible in 
lanes which there is no distinct E2 MRE band.  This is likely due to degradation of the genomic 
DNA present in the sample.  In both E2:SWCNT samples amplification of a product just less 
than 50 bp increases with E2:SWCNT concentration.  This is also true for E2:SWCNT PCRs 
performed with no free E2 MRE in the reaction (Figure 4.1e and f).  This is likely due to an 
excess of the amplification target itself in the reaction.  However, in the TG15:SWCNT PCRs, 
no amplicons appeared that were not present in the control reaction.   
4.3.3 Agarose Gel Analysis of New DNA:SWCNT PCRs 
 Analysis of PCRs performed with DNA:SWCNT samples made less than a month before 
use show amplification in the presence of 0.01 mg/mL (Figure 4.2 agarose gels).  At this 
concentration, all PCRs performed in the presence of free E2 MRE showed an increase in 
efficiency of amplification (Figure 4.2 relative intensities).  However, in contrast to PCRs with 
old DNA:SWCNT samples, no amplification of E2 MRE was seen at or above concentrations of 
0.1 mg/mL.  This interesting result suggests that more well-dispersed SWCNT, as seen in the 
older samples, is less inhibitory to PCR reactions.  This may be because more agglomerated 




Figure 4.2. (a-d). Agarose gel electrophoresis images and analysis of PCRs with new (<1 month) 
DNA:SWCNT samples. For each set, top left is agarose gel image with lanes and quantitized boxes 
shown, top center is intensity line graph, top right is NS1 synthesized fluorescence intensity plot of 
DNA:SWCNT samples (y-axis is excitation wavelength, x-axis is emission wavelength), bottom left is 
bar graph of relative intensity within boxes on gel (normalized to 100 bp marker of 25 bp ladder), bottom 
center is fluorescence efficiency at each wavelength in NS1 analysis (higher numbers correlate with 
greater dispersion).  Lanes in agarose gel images and relative intensity bar graph: 1. 25 bp ladder (black) 
2. empty (dark blue) 3.  negative control (red) 4. positive control (green) 5. 0.01 mg/mL DNA:SWCNT 
(purple) 6. 0.1 mg/mL (neon blue) 7. 1 mg/mL (orange) 8. 5 mg/mL (light blue) 9. 10 mg/mL (pink)10. 
100 bp ladder (black).  Intensity line graph colors correlate with bar graph colors in relative intensity 














Figure 4.2. (e-h). Agarose gel electrophoresis images and analysis of PCRs with new (<1 month) 
DNA:SWCNT samples. For each set, top left is agarose gel image with lanes and quantitized boxes 
shown, top center is intensity line graph, top right is NS1 synthesized fluorescence intensity plot of 
DNA:SWCNT samples (y-axis is excitation wavelength, x-axis is emission wavelength), bottom left is 
bar graph of relative intensity within boxes on gel (normalized to 100 bp marker of 25 bp ladder), bottom 
center is fluorescence efficiency at each wavelength in NS1 analysis (higher numbers correlate with 
greater dispersion).  Lanes in agarose gel images and relative intensity bar graph: 1. 25 bp ladder (black) 
2. empty (dark blue) 3.  negative control (red) 4. positive control (green) 5. 0.01 mg/mL DNA:SWCNT 
(purple) 6. 0.1 mg/mL (neon blue) 7. 1 mg/mL (orange) 8. 5 mg/mL (light blue) 9. 10 mg/mL (pink)10. 
100 bp ladder (black).  Intensity line graph colors correlate with bar graph colors in relative intensity 














fact that higher concentrations have an inhibitory effect on PCR efficiency.  However, in both 
old and new samples, there seems to be no difference in PCR efficiency between Mix or (6,5)-
enriched SWCNT samples.  This is in spite of a difference in dispersion based on DNA 
sequence.     
 In PCR experiments with new E2:SWCNT samples and absent of free E2 MRE, the MRE 
was amplified from the SWCNT scaffold (Figure 4.2g and h.  Amplification of the 76 bp product 
is observed in the presence of 0.01 mg/mL E2:SWCNT, but not at higher concentration.  This 
follows the same pattern seen as PCRs done in the presence of free E2 MRE.  There is, however, 
a reduction in efficiency at this concentration, which contradicts amplification of free E2 MRE at 
this concentration.   
 Amplicons produced from PCRs in the presence of new DNA:SWCNT followed the 
same general pattern as those with old samples.  Previous studies have shown SWCNT increase 
the specificity of long PCR (14 kb) up to the point that the reaction is inhibited (Zhang et al. 
2008).  The difference in results may be a function of size of the reaction product, or may be due 
to the method of SWCNT dispersion, which was sonication in water.  Another study has shown 
that different concentrations of carbon nanopowder (CNP) does not affect amplicons produced in 
a PCR reaction (Zhang et al. 2007).  Therefore, the effects are likely due to degradation of 
genomic DNA or excess target present in the reaction as previously discussed. 
4.4 Conclusions 
 This work shows differential inhibitory concentrations for old and new DNA:SWCNT 
preparations of varying dispersion levels in PCR reactions of 0.1 and 0.01 mg/mL, respectively.  
This work also shows that it is possible to amplify a DNA sequences that is directly associated 
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with SWCNTS through sonication-mediated dispersion.  This is important for purification of 
SWCNT chiralities using DNA as well as use of DNA:SWCNT-based molecular sensors and 

















































Investigation of the Effects of DNA-Dispersed Single-Wall Carbon Nanotubes 
and Sodium Cholate-Dispersed Single-Wall Carbon Nanotubes on the Green 






































   5.1 Introduction 
 The increased use of manufactured nanomaterials has led to a need for a better 
understanding of their potential effects on natural systems.  Among these products are carbon 
nanotubes, which can be represented by sheets of cylindrically-rolled graphene, originally 
described in 1991 by Iijima (Iijima 1991; Ajayan 1999).  The widespread commercialization of 
single-wall carbon nanotubes (SWCNT) is due to their enormous potential in industrial, 
biomedical, and electronic sensing applications.  This potential is derived from their unique 
physical, electronic, and optical properties (Wang 2005; Coleman et al. 2006; Huang et al. 2011).  
The environmental release and transport of SWCNT at all stages of their production and use will 
lead to environmental concerns (Köhler et al. 2008; Petersen et al. 2011).  It is because of their 
potential that it is necessary to study their interaction with organisms in the environment. 
 Previous work has shown possible toxic effects of carbon nanomaterials on model 
organisms.  Graphite, C60 fullerene, SWCNT, and multi-wall carbon nanotubes (MWCNT) have 
been shown to inactivate various Gram-negative and Gram-positive bacteria (Kang et al. 2009).  
This was shown to increase with incubation times up to four hours.  While in the aforementioned 
work the SWCNT contacted bacteria on a solid support, SWCNT dispersed in solution with 
various surfactants have shown to be toxic to both bacterial types (Liu et al. 2009).  In the model 
organism Daphnia magna, SWCNT suspended in water with no surfactant were the most toxic 
among other carbon nano- and bulk- materials (Zhu et al. 2009).  These previous works make it 
clear that SWCNT may have toxic environmental effects, but further exploration of various 
preparations is necessary. 
 The unicellular green alga Chlamydomonas reinhardtii has been developed as a model 
for the effects of nanomaterials on photosynthetic and microorganisms, as well as an indirect 
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assessment of ecosystem-level effects (Harris 2001).  Work using this model organism has 
shown toxicity of silver nanoparticles, quantum dots, and titanium dioxide nanoparticles 
(Navarro et al. 2008; Wang et al. 2008).  A subsequent study has shown that this species takes up 
quantum dots, which cause changes in its transcription profile (Domingos et al. 2011).  
Additionally, C. reinhardtii has been used in finding toxic effects of SWCNT in solution with no 
surfactant (Matorin et al. 2010).  This work showed a negative effect on growth and 
photosynthetic output of these algae due to SWCNT aggregates in solution.  It specifically tested 
concentrations of 2 µg/mL for SWCNT and 1 and 2 µg/mL of MWCNT, finding varying 
negative effects of each.  Thus, C. reinhardtii is an established system for studying the direct 
toxic effects of nanomaterials and for inferring environmental impact of their release. 
 This study aimed to determine the effects of well-dispersed SWCNT on the model 
species Chlamydomonas reinhardtii.  The system was designed to mimic a stagnant algal growth 
environment that is similar to natural systems.  This design is ideal for well-dispersed SWCNT, 
however non-dispersed SWCNT would agglomerate and form a precipitate in such a system.  
Thus, only well-dispersed SWCNT were utilized, mimicking the environmental release of some 
SWCNT (Köhler et al. 2008).  Additionally, agglomerated SWCNT are known to become more 
well-dispersed over time through interaction with natural organic matter (Lou et al. 2011; 
Schierz et al. 2012).  Therefore, the effects of a wide range of well-dispersed SWCNT in solution 
with algal growth media on growth and chlorophyll content of green algae was assessed.  
Furthermore, differences in surfactants used to disperse SWCNTs were explored.  
Deoxyribonucleic acid (DNA) has been utilized to wrap around SWCNT and disperse them 
individually in solution (Zheng et al. 2003), while sodium cholate (SC) is a biocompatible 
surfactant which disperses SWCNT well in solution (Wenseleers et al. 2004; Arnold et al. 2006).  
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Herein, DNA-and SC-dispersed SWCNT are characterized by near-infrared (NIR) spectroscopy 
and their toxicity to C. reinhardtii is determined. 
5.2 Methods 
5.2.1 SWCNT Preparation 
 Single-wall carbon nanotubes dispersed by either DNA or SC (DNA:SWCNT or 
SC:SWCNT)  preparations were made similar to as previously described (Zheng et al. 2003; 
Lahiji et al. 2007).  Briefly, 2 mg CoMoCAT SWCNT of mixed chirality (Sigma-Aldrich; St. 
Louis, MO) were mixed with 2 mg salmon testes genomic DNA or SC in 2 mL 1X phosphate-
buffered saline (PBS).  This mixture was sonicated on ice for two hours with a Virsonic XL2020 
ultrasonic liquid processor (Misonix; Farmingdale, NY) equipped with a 3.2 mm microtip at 
approximately 20% power.  The resulting solution was centrifuged at 16,000Xg for 90 minutes 
to remove insoluble SWCNT.  For DNA:SWCNT samples, the solution was then filtered through 
a 100,000 molecular weight centrifugal filter (Millipore; Billerica, MA) three times at 4000 RPM 
for 15 minutes each to remove DNA that did not associate with SWCNTs.  The recovered 
DNA:SWCNT solution was brought to a volume of 500 µL with 1X PBS, while SC:SWCNT 
samples remained in 2 mL.  The concentration of the DNA: or SC:SWCNT samples were 
obtained by gravimetric analysis of 10 µL of the solution weighed on an Ohaus Discovery 
Microbalance (Ohaus; Parsippany, NJ).   
5.2.2 SWCNT Characterization 
 Absorption and NIR fluorescence measurements were performed essentially as 
previously described (Bachilo et al. 2002; Weisman 2010).  Briefly, each SWCNT preparation 
was diluted to a 1% solution with Milli-Q water (Millipore; Billerica, MA).  This solution was 
added to a 10 mm path length cuvette (Sterna Cells; Atascadero, CA) and analyzed on a 
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NanoSpectralyzer 1 (NS1) (Applied NanoFluorescence; Houston, TX).  The absorbance 
spectrum was collected from 400 - 1600 nm.  Additionally, integrated fluorescent emission 
spectra were obtained using excitation wavelengths of 638 nm, 690 nm, and 784 nm.  The 
resulting spectra were analyzed with ANFSoft (Applied NanoFluorescence; Houston, TX) and 
prepared in Origin 8 (OriginLab Corporation; Northampton, MA).  Fluorescence efficiency 
measurements, which are fluorescence power collected across the emission spectrum for a single 
excitation wavelength divided by the absorbance spectrum, are reported as a relative measure of 
SWCNT dispersion in solution. 
5.2.3 Algae Culture 
 Chlamydomonas reinhardtii wild-type strain cc-1690  was obtained from the 
Chlamydomonas Resource Center (St Paul, MN).  Received algae were initially plated onto 1.5% 
Sueoka's high salt medium (HSM) agar prepared as previously described (Sueoka 1960).  This 
was used to seed small liquid cultures of HSM for outgrowth, which was kept in a continuous 
culture of 100 mL HSM.  Every 1-2 weeks, the existing culture was diluted to 10% in HSM to 
allow continuous outgrowth.  Culture conditions were sustained at 22-25°C with continuous 
ambient light and daily mixing.   
5.2.4 SWCNT Treatments 
 Treatments of C. reinhardtii in liquid culture with SWCNT preparations or controls were 
performed in a total volume of 10 mL in 50 mL conical tubes with loosened lids.  At day zero, 9 
mL HSM was seeded with 1 mL stock algal culture and the appropriate treatment was added.  
Treatments were: 0, 0.1, 1, 2, 10, or 100 µg/mL DNA:SWCNT or SC:SWCNT, and 100 µg/mL 
sonicated DNA or SC.  Contamination and absorbance controls consisted of 10 mL of just HSM 
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or HSM with 1 µg/mL DNA:SWCNT or SC:SWCNT.  Each treatment and control was 
performed in triplicate and grown for ten days at the above-noted culture conditions.   
5.2.5 Growth Measurements 
 Every 24 hours, from day one to day 10, each sample was mixed and 300 µL was 
removed.  The optical density of this solution was measured at 750 nm with a Synergy 2 
microplate reader and the software Gen5 1.06 (Biotek US; Winooski, VT).  The optical density 
at 750 nm was also measured for prepared absorbance controls of HSM with each individual 
treatment.  The optical density of algae was determined by subtracting control from sample 
optical density.  On the tenth day, optical density of Chlorophyll β and α at 663 nm and 645 nm 
respectively was obtained.  A portion of each sample was centrifuged and resuspended in 
methanol.  This was centrifuged, and optical density of chlorophyll extracted in the liquid phase 
was measured at 663 nm and 645 nm as previously described (Chochois et al. 2010).  At the end 
of treatments, algae were placed onto microscope slides with a cover slip and imaged using a 
Leica ATC 2000 light microscope (Leica Microsystems; Wetzlar, Germany) and a TCA 5.0 
microscope camera (Ample Scientific; Norcross, GA). 
5.3 Results and Discussion 
5.3.1 SWCNT Preparation and Characterization 
 Single-wall carbon nanotubes were dispersed in solution with either DNA or SC.  As 
determined by gravimetric analysis, concentrations of prepared SWCNT solutions ranged from 
10 µg/µL to 30 µg/µL.  Absorbance and NIR fluorescence spectroscopy was then performed on 
dilutions of each sample to determine SWCNT chirality composition, diameter, and dispersion in 
solution (Figures 5.1a and 5.1b).  The DNA:SWCNT showed an average SWCNT diameter of 
0.83 nm, ranging from 0.6 to 1.4 nm (Figure 5.1c).  Based on an integrated fluorescence 
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emission spectrum, the sample of mixed chirality was composed of largely (6,5), (8,4), and (7,5) 
armchair SWCNT (Figure 5.1e).  The SC:SWCNT sample had an average of 1.248 nm, with 
SWCNT being mostly between 1.2 and 1.3 nm (Figure 5.1d).  The integrated fluorescence 
emission spectrum of this sample showed a majority of SWCNT being of (11,7) armchair 
chirality (Figure 5.1f).  Additionally, efficiency of fluorescence output of the DNA:SWCNT was  
much higher than SC:SWCNT, which were negative values (Figures 5.1g and 5.1h).  NIR 
fluorescence is only emitted from monodisperse SWCNT suggesting DNA is more effective 
at dispersing individual SWCNTs than SC (Zheng et al. 2003; Wenseleers et al. 2004; Liu et al. 
2009).  DNA gives more monodisperse SWCNT by wrapping around the SWCNT in a helical 
manner masking the hydrophobic surface of the SWCNT.  In contrast, SC forms micelles which 
disperse SWCNT as bundles.  Therefore, fluorescence efficiency and SWCNT diameter of each 
SWCNT sample confirms that DNA:SWCNT are more well-dispersed than SC:SWCNT.   
5.3.2 Effects of SWCNT and Dispersion Method on Algal Growth 
 Chlamydomonas reinhardtii were grown in liquid culture with either DNA:SWCNT, 
SC:SWCNT, or controls and the culture optical density was measured for ten consecutive days.  
Results show no normalized optical density for either the high salt medium or 1 µg/mL 
DNA:SWCNT only controls, meaning no contamination of media or SWCNT sample was 
present (Figure 5.2).  From culture concentrations of 0.1 µg/mL to 100 µg/mL, there are no 
effects of DNA:SWCNT on optical density of the algae.  For all cultures, a plateau in algal 
growth was reached in the sixth day.  There is also no difference with treatment of 100 µg/mL 







Figure 5.1. Characterization of DNA:SWCNT and SC:SWCNT. (a) and (b) Synthesized 
fluorescence intensity plot of DNA:SWCNT and SC:SWCNT output respectively. (c) and (d) 
Calculated density distribution of DNA:SWCNT and SC:SWCNT respectively. (e) and (f) 
SWCNT chirality distribution of DNA:SWCNT and SC:SWCNT samples respectively. (g) and 
(h) Fluorescence efficiency measurements at excitation wavelengths of 638, 690, and 784 nm of 
DNA:SWCNT and SC:SWCNT respectively. Higher numbers represent better dispersion. 
 
DNA:SWCNT 638 nm 690 nm 784 nm
Efficiency 1.09507 0.75541 1.6632
SC:SWCNT 638 nm 690 nm 784 nm








 Results of algae grown in the presence of SC:SWCNT also show no difference in algal 
growth optical density at 750 nm due to SC:SWCNT treatment (Figure 5.3).  A plateau in growth 
is evident beginning at day four.  There is an initial difference in growth of algae treated with 
just 100 µg/mL SC at the plateau, which subsides by the ninth day.  At the ninth and tenth day, 
there is an increase in growth of algae treated with 0.1 µg/mL, however this is not significant.  
Growth of SC only-treated algae plateaus at day 6; however standard deviations also overlap 
with the control at these days suggesting no true difference. 
 
Figure 5.2. Ten day growth curve of Chlamydomonas reinhardtii with DNA:SWCNT 
treatments or controls. Treatments were 0, 0.1, 1, 2, 10, or 100 µg/mL, DNA:SWCNT only 
control, media only control (HSM), or 100 µg/mL DNA control. Errors bars for each point 
represent (+/-) standard deviation. 
 After the tenth day, extraction of chlorophyll and absorbance measurements at 663 nm 
and 645 nm gave chlorophyll content measurements of the algal cultures.  At 663 nm, 
absorbance of chlorophyll β showed no difference between either DNA:SWCNT or SC:SWCNT 

































dispersed SWCNT at any treatment concentration.  There is a decrease in SC-only treated algae, 
however.  This may be due to some mitigation by SWCNT being complexed with SC.  
Chlorophyll α absorbance at 645 nm showed similar results (Figure 5.5).  There is no difference 
between controls and treatments of DNA:SWCNT and SC:SWCNT at any treatment level.   
 
Figure 5.3. Ten day growth curve of Chlamydomonas reinhardtii with SC:SWCNT 
treatments or controls. Treatments were 0, 0.1, 1, 2, 10, or 100 µg/mL, SC:SWCNT only 
control, media only control (HSM), or 100 µg/mL SC control. Errors bars for each point 
represent (+/-) standard deviation.   
 There seems to be no difference in Chlamydomonas reinhardtii growth or chlorophyll 
output for DNA:SWCNT or SC:SWCNT treatment relative to control.  This is in opposition to 
previously-reported data showing negative growth effects of SWCNT.  Previous findings using 2 
µg/mL SWCNT with no surfactant showed a negative effect on growth of algae up to five days 
(Matorin et al. 2010).  This report also showed clear evidence of algal association with SWCNT 
agglomerations.  Non-dispersed SWCNT have also shown to be toxic to bacteria (Kang et al. 

































and almost 50 times greater caused no growth effects in the current study.  While the stagnant 
growth conditions used in this study were not conducive to using non-dispersed SWCNT due to 
hydrophobic precipitation, the previously-reported studies are a comparative benchmark for their 
toxic effects.  The use of well-dispersed SWCNT is environmentally relevant as agglomerations 
are known to associate with organic matter and become more well-dispersed over time (Lou et 
al. 2011; Schierz et al. 2012).  The extensive studies reported herein suggest there is no negative 
effect of well-dispersed SWCNT on algal growth. 
  The reported toxic effect of SWCNT may be due to agglomeration and shading, which 
was mitigated in this study with more effective dispersion of the SWCNTs.  It has been reported 
that SWCNT toxic effects on the green algae Pseudokirchneriella subcapitata were lost with 
higher concentrations of the surfactant Gum Arabic (Youn et al. 2011).  Another study 
specifically investigating the effects of agglomeration and shading found that SWCNT partially 
dispersed by natural organic matter had EC50 values of 1.8 µg/mL and 20 µg/mL on the algae 
Chlorella vulgaris and P. subcapitata (Schwab et al. 2011).  That work suggests that toxic 
effects may be due to indirect effects on local growing conditions of algae within SWCNT 
agglomerations, such as competition for resources and reduced light availability. 
 In the current study, agglomeration and shading by SWCNT did not seem to be as 
prevalent.  No agglomeration of DNA:SWCNT samples were seen either in culture or in 
micrographs (Figure 5.6).  At the highest level of SC:SWCNT treatment, 100 µg/mL, there was 
some visible agglomeration in culture and under the microscope, but this was not extensive nor 
was it found at any lower levels.  However, microscopic examination shows only a small portion 
of algae are agglomerated with SC:SWCNT, not nearly as prevalent as with the P. subcapitata 




Figure 5.4. Extracted Chlorophyll β content at OD 663 for DNA:SWCNT and SC:SWCNT 
treatments. Treatments are 0, 0.1, 1, 2, 10, or 100 µg/mL, DNA:SWCNT or SC:SWCNT only  
 
Figure 5.5. Extracted Chlorophyll α content at OD 645 for DNA:SWCNT and SC:SWCNT 
treatments. Treatments are 0, 0.1, 1, 2, 10, or 100 µg/mL, DNA:SWCNT or SC:SWCNT only 
control, media only control (HSM), or 100 µg/mL DNA or SC control. Error bars for each point 











































Additionally, the chosen strain can grow in the presence of nitrogen in the dark and therefore 
may not be affected by SWCNT shading effects.  Results of chlorophyll content measurements 
however show no difference due to SC:SWCNT at any level.  Future work may determine 
possible effects on chlorophyll efficiency due to agglomeration and shading.  Hence, the lack of 
toxic SWCNT effects is likely due to the well-dispersed nature of DNA:SWCNT and 
SC:SWCNT.  Indeed, work with SWCNT well-dispersed in various surfactants on rat liver cells 
and human lung fibroblasts showed no toxic effects (Alpatova et al. 2010; Wang et al. 2010).  
Furthermore, DNA:SWCNT and SC:SWCNT showed no toxic effect on human astrocytoma 
cells (Dong et al. 2008).  A lack in difference of growth between DNA:SWCNT and 
SC:SWCNT, even though DNA:SWCNT are more well-dispersed, may be because SC:SWCNT 
do not agglomerate to the point of causing a wide-scale effect on growth.   
 
Figure 5.6. Micrograph of algae grown with SWCNT. Representative image of 
Chlamydomonas reinhardtii after ten days in culture with 100 µg/mL DNA:SWCNT.  Algae 
appear healthy and no SWCNT agglomerations are visible. 
 A detraction from this hypothesis is a study showing that SWCNT act as 'nano darts'.  In 
this, well-dispersed SC:SWCNT effectively punctured bacterial membranes (Liu et al. 2009).  
This work states that softer bacterial membranes were more susceptible to puncturing by 
SWCNT, and therefore may not be a factor with the prominent glycoprotein cell wall of C. 
reinhardtii (Harris 2001).  It was also noted that a higher rate of bacterial death was obtained by 
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faster shaking speeds with SWCNT.  This was not a factor here as cultures were only mixed once 
a day.  Future studies may be directed to investigate increased shaking speeds of DNA:SWCNT 
and SC:SWCNT treated cultures.  The presented work does, however, agree with other 
toxicological studies using DNA:SWCNT and SC:SWCNT to treat human cells (Dong et al. 
2008).  It is therefore unlikely that SWCNT punctured the cell wall of the algae or had any other 
negative effects.  Future work may further investigate the nature of the interaction seen in 
SC:SWCNT agglomerations and investigate the ability of monodisperse SWCNT to penetrate 
algal cell walls.   
5.4 Conclusions 
 This study presents findings that SWCNT well-dispersed with DNA or SC does not have 
an effect on growth or chlorophyll content of Chlamydomonas reinhardtii at concentrations of 
0.1-100 µg/mL.  This is in opposition to previous work that has shown SWCNT can be toxic to 
algae, bacteria, or other model organisms.  However, this supports other research that suggests 
there is no toxic effect of well-dispersed SWCNT on model organisms or mammalian cells.  
Thus, increasingly widespread use of SWCNT may have toxic environmental impacts if the 
materials are poorly dispersed in solution.  However, well-dispersed SWCNT, such as those with 
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 Prostate cancer is the most-diagnosed non-skin cancer in the United States, with an 
estimated 241,740 new diagnoses in 2012 alone (Siegel et al. 2012).  It is the second leading 
cause of cancer-related deaths among males in the U.S., with an estimated 28,170 mortalities in 
2012 (Siegel et al. 2012).  Approximately one in six U.S. men will get prostate cancer in their 
lifetime, with one in 30 dying from the disease (Ries et al. 1997).  It is therefore important to 
develop new diagnostic and therapeutic approaches for clinical prostate cancer treatment. 
 Currently, prostate cancer diagnosis has shifted away from the standard of care: prostate 
specific antigen (PSA) blood levels.  Initially discovered in 1979, serum PSA levels were shown 
to be higher in men with prostate cancer than those with normal prostates (Wang et al. 1979; 
Kuriyama et al. 1980).  After U.S. Food & Drug Administration approval for prostate cancer 
detection in 1986, there was an initial increase in number of prostate cancer-related deaths, 
largely due to more diagnoses (Catalona et al. 1991; Baade et al. 2004).  This mortality rate 
began to decrease due to better awareness, however, as PSA had become the standard bearer in 
cancer biomarkers (Baade et al. 2004).   
In spite of this promise, PSA testing is no longer recommended for use by the United 
States Preventative Services Task Force (USPSTF) (Chou et al. 2011; Lin et al. 2011; Moyer 
2012).  This is because serum PSA levels are raised not only due to cancerous prostates, but due 
to benign prostatic conditions such as prostatic intraepithelial neoplasia (PIN), benign prostate 
hyperplasia (BPH), and prostatitis (Woolf 1995).  Indeed, studies have shown the specificity of 
the PSA test in prostate cancer diagnosis to be just 24%, meaning there is a 76% over-diagnosis 
rate (Thompson et al. 2006).  Calculations have shown that PSA screening will prevent just one 
prostate cancer-related death in greater than 1000 men (Moyer 2012).  For that small number is 
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does help, it is estimated to cause many unnecessary biopsies, treatments, and individual stress 
(Carlsson et al. 2012; Moyer 2012).  For that reason, the USPSTF officially gave it a grade ‘D’ 
in 2012; however some primary care physicians continue to use the test due to its high sensitivity 
(Barry 2009; Moyer 2012; Pollack et al. 2012).   
The promise of PSA, despite its pitfalls, has led to a great deal of research in identifying 
other diagnostic mechanisms.  There have been many biomarkers identified that may have some 
diagnostic potential (Herness and Naz 2001; Williams and Naz 2010).  Many of these, however, 
do not differentiate between prostate cancer and other prostatic diseases, similar to PSA.  Others 
are expressed in other tissues and are not useful for identification of prostate cancer.  The most-
studied among these is prostate-specific membrane antigen (PSMA), which has entered into the 
clinic as a diagnostic and therapeutic tool (Horoszewicz et al. 1987).  PSMA, however, is 
expressed in other non-prostatic normal and malignant tissues (Maraj et al. 1998; Renneberg et 
al. 1999).  Thus, clinical prostate cancer diagnosis relies on digital rectal exams, which can miss 
tumors, relies on diagnosis after palpable tumors have formed, and misses more prostate tumors 
than PSA screening (Catalona et al. 1994).  Additionally, biopsies are performed, which are 
invasive and have inherent infection risks (Rodriguez and Terris 1998).  Therefore, it is 
necessary to develop a minimally invasive diagnostic molecular test for the early and specific 
detection of prostate cancer. 
In addition to non-specific diagnostics, current treatments for prostate cancer are partially 
effective, but have many unwanted side effects.  Early-stage, localized prostate cancer is 
typically either managed with watchful waiting or treated with prostatectomy, radiation therapy, 
androgen deprivation, cryotherapy, or ultrasonogrpahy (Chou et al. 2011).  Long-term studies 
have found that radical prostatectomy confers a significant decrease in mortality compared to 
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watchful waiting, from 21% to 15% in one trial (Wong et al. 2006; Albertsen et al. 2007; Bill-
Axelson et al. 2008; Bill-Axelson et al. 2011).  In total, radiotherapy, including external beam 
radiation therapy and internal brachytherapy, significantly reduces prostate cancer-related 
mortality compared to no treatment (Tewari et al. 2007; Zhou et al. 2009; Ladjevardi et al. 2010; 
Stattin et al. 2010).  Conversely, androgen deprivation therapy is actually associated with 
increased risk of mortality, however one study found a slight decrease after a seven year 
followup period (Lu-Yao et al. 2008; Zhou et al. 2009).  
 Each of the localized prostate cancer treatment modalities is associated with multiple 
side-effects.  These include urinary incontinence, erectile dysfunction, and quality of life, among 
others (Chou et al. 2011).  In fact, depending on the treatment, a 14-33% higher proportion of 
men, compared to watchful waiting, suffered from erectile dysfunction and a 20% higher 
proportion of men had urinary incontinence (Chou et al. 2011).  For prostatectomy, operation-
related mortality and cardiac events are possible (Yao and Lu-Yao 1999).  Additionally, 
recurrence is possible with all of these treatments.  This can be in a more aggressive, androgen-
independent form, or other hard-to-treat forms (Feldman and Feldman 2001).  For many non-
localized cancers, chemotherapy is also used.  This is in spite of the fact that many advanced, 
hormone-refractory prostate cancers are difficult to treat with chemotherapeutics (Yagoda and 
Petrylak 2006).  For prostate cancer, historically 5-fluorouracil (5-FU) was used and had fewer 
side effects compared to those used today (Yagoda and Petrylak 2006).  Currently, docetaxel is 
the first-line chemotherapeutic, with mitoxantrone sometimes being used in that role based on 
side effects (Pienta 2001; Pienta and Smith 2005).  These are often used with combinations of 
other agents as well (Pienta and Smith 2005).  However, whether alone or in combination, these 
cause many side effects due to non-specific action.  A 70% response rate has been shown for 
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patients on docetaxel, however as many as 70% of all patients also experienced neutropenia 
(Extra et al. 1993).  Other main side effects include thrombosis, fatigue, hyperglycemia, nausea, 
vomiting, and others (Pienta and Smith 2005).  Clearly, these drugs can be effective, however 
more specific therapeutics would be more effective and have fewer side effects. 
It is possible to utilize molecular targeting to diagnose and specifically deliver 
therapeutics to prostate cancer.  Identification of a Molecular Recognition Element (MRE) is 
achieved through the process of Selective Evolution of Ligands by EXponential Enrichment 
(SELEX), also known as in vitro selection (Ellington and Szostak 1990; Tuerk and Gold 1990).  
This process utilizes a large library of random molecules which are screened for their ability to 
bind to a target of interest.  Those that do not bind to the target are removed, and those that do 
are amplified.  Amplified molecules are then subjected to closely-related negative targets to 
which binding is not desired.  Molecules that do not bind to this target are amplified, completing 
a round of selection.  Rounds continue until one or a few strongly-binding and specific molecules 
are selected.  This process has been adapted for use in identifying molecules that bind to whole-
cell targets (Morris et al. 1998; Guo et al. 2008).  It has also been adapted to incorporate a 
protein library displayed on various microbiological host surfaces, including yeast (Huse et al. 
1989; Gunneriusson et al. 1996; Boder and Wittrup 1997).  It is therefore possible to combine 
these methodologies to identify protein MREs from a yeast-displayed library which bind to the 
surface of prostate cancer cells. 
The work described here utilized a novel variation of SELEX called Decoy-SELEX.  
This scheme enriches the initial library for molecules which bind to the target of interest similar 
to SELEX.  It focuses, however, on stringent negative selections using targets to which the MRE 
should not bind.  This work has identified MREs which bind to a prostate cancer cell line, and 
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not to various benign prostate cells lines.  It utilized a human non-immune single-chain Fragment 
variable (scFv) library displayed on the surface of Sacchoromyces cerevisiae.  The obtained 
MREs will be useful for both specific diagnosis and treatment of prostate cancer. 
A.2 Methods 
 The Decoy-SELEX process was used in order to obtain a prostate cancer cell-specific 
MRE (Figure A.1).  A library of non-immune human single-chain Fragment variable (scFv) 
antibody fragments was displayed on the surface of yeast.  Seven rounds of selection were 
completed, enriching  for those scFvs which bound to the androgen-dependent prostate cancer 
cell line LNCaP and subtracting those that bound to the benign prostate cell lines HGPIN, BPH-
1, and BHPrE1, as well as the protein PSMA (Table A.1). 
 
Figure A.1. Scheme depicting the Decoy-SELEX process. A library of 109 yeast-displayed 
scFv molecules are incubated with the target LNCaP cell line.  Those that bind are amplified and 
incubated with negative targets.  Those that do not bind the negative targets are amplified and 






A.2.1 Cell Culture and Materials 
 In order to obtain a prostate cancer cell-specific MRE, prostatic cell lines were used.  For 
general maintenance, each line was passaged every 5-7 days in a T75 cell culture dish with 
media changed every 2-3 days.  The cells were grown in a 37°C incubator with 5% carbon 
dioxide and humidity.  The androgen-dependent prostate cancer cell line LNCaP was obtained 
from the American Type Culture Collection (ATCC) (Manassas, VA) and cultured in RPMI 
1640 with L-Glutamine and 25 mM HEPES (Cellgro; Manassas, VA) and 10% Fetal Bovine  
Serum (FBS) (Fisher Scientific; Pittsburgh, PA) and 1X antibiotic/antimycotic mixture (ab/am) 
(Cellgro) (Horoszewicz et al. 1983).  The HPV-18-immortalized High Grade Prostatic 
Intraepithelial Neoplasia (HGPIN) cell line was a generous gift from Dr. Mark Stearns (Drexel 
University; Philadelphia, PA) and was cultured in Defined KSFM (Gibco; Grand Island, NY) 
with 5% FBS and 1X ab/am (Wang et al. 1999).  The SV40T-immortalized Benign Prostate 
Hyperplasia (BPH-1) cell line was a generous gift from Dr. Simon Hayward (Vanderbilt 
University; Nashville, TN) and was cultured in RPMI-1640 with L-Glutamine and 25 mM 
HEPES and 10% FBS and 1X ab/am (Hayward et al. 1995).  The spontaneously-immortalized 
intermediate prostate stem cell line BHPrE1 was also obtained as a generous gift from Dr. Simon 
Hayward (Vanderbilt University) and cultured in DMEM/F12 (Cellgro) supplemented with 5% 
FBS, 1X ab/am, 1% insulin/transferrin/selenium (Gibco), 0.4% bovine pituitary extract (Sigma; 
St. Louis, MO), 5 ng/mL epidermal growth factor (Gemini Bio-Products; West Sacramento, 
CA), and 1X ab/am (Jiang et al. 2009).  The androgen-independent DU-145 prostate cancer cell 
line was obtained from ATCC and cultured in EMEM (Cellgro) with 10% FBS and 1X ab/am 
(Stone et al. 1978).  The androgen-independent prostate cancer cell line PC-3 was also obtained 
from ATCC and cultured in F12K media (Cellgro) with 10% FBS and 
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Table A.1. Decoy-SELEX scheme for identification of prostate cancer cell-specific MREs. 
Selection 









Time  Volume  
Separation 
Method  
1 (+)  LNCaP  1 X 1010  34.2  ~8 X 106  3 hours  15 mL  Panning  
1 (-)  
HGPIN  
1 X 1010  38.5  
~7 X 106  30 minutes  
15 mL  Panning  BPH-1  ~9 X 106  30 minutes  
BHPrE1  ~7.5 X 106  30 minutes  
2 (+)  LNCaP  1 X 1010  7.04  ~9 X 106  2 hours  15 mL  Panning  
2 (-)  
HGPIN  
1 X 1010  6.34  
~8.5 X 106  1 hour  
15 mL  Panning  BPH-1  ~9.5 X 106  1 hour  
BHPrE1  ~8 X 106  1 hour  
3 (+)  LNCaP  1 X 1010  8.85  ~9 X 106  1 hour  15 mL  Panning  
3(-)  
HGPIN  
1 X 1010  6.7  
~7 X 106  2 hours  
15 mL  Panning  BPH-1  ~9 X 106  2 hours  
BHPrE1  ~8 X 106  2 hours  
4 (+)  LNCaP  1 X 107  29.65  1 X 106  30 minutes  2.5 mL  FACS  
4 (-) a  HGPIN  1 X 107  6.31  1 X 106  30 minutes  1.5 mL  FACS  
4 (-) b  BPH-1  1 X 107  7.65  1 X 106  30 minutes  2 mL  FACS  
4 (-) c  BHPrE1  1 X 107  4.78  1 X 106  30 minutes  1.5 mL  FACS  
4 (-) d  PSMA*  1 X 107  17.3  
1 nmol 
protein  30 minutes  1 mL  FACS  
5 (+)  LNCaP  1 X 107  
24.02 
(Lo)/21.72 
(Hi)  1 X 106  30 minutes  5 mL  FACS  
6 (+)  LNCaP  1 X 107  21.2/19.36  1 X 105  30 minutes  2.75 mL  FACS  
6 (-) a  HGPIN  1 X 107  16.73/13.5  1 X 106  30 minutes  2.5 mL  FACS  
6(-) b  BPH-1  1 X 107  7.86/11.92  1 X 106  30 minutes  2.5 mL  FACS  
6(-) c  BHPrE1  1 X 107  41.42/48.85  1 X 106  30 minutes  2.5 mL  FACS  
6(-) d  PSMA*  1 X 107  37.26/8.53  
1 nmol 
protein  30 minutes  2 mL  FACS  
7 (+)  LNCaP  1 X 107  25.67/15.63  1 X 103  30 minutes  2.5 mL  FACS  
*PSMA is prostate-specific membrane antigen. 
 
1X ab/am (Kaighn et al. 1979).  The HPV-18-immortalized normal prostatic epithelium cell line 
RWPE-1 was obtained from ATCC and cultured in Defined KSFM (Gibco) plus 1X ab/am 
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(Bello et al. 1997).  The spontaneously-immortalized early prostate stem cell line NHPrE1 was a 
generous gift from Dr. Simon Hayward (Vanderbilt University) and cultured in the same media 
as BHPrE1 (Jiang et al. 2009). 
A.2.2 scFv Library and Growth 
 A human non-immune scFv library displayed on the surface of Sacchoromyces cerevisiae 
with 109 diversity was a gift from Dr. Dane Wittrup (Massachusetts Institute of Technology; 
Cambridge, MA) (Boder and Wittrup 1997; Feldhaus et al. 2003).  The library had a full 
diversity of at least 109 antibody fragments and has the ability to be serially propagated without 
loss of diversity (Feldhaus et al. 2003).  The full library was cloned into the pPNL6 plasmid in 
the EBY100 yeast strain.  It was originally amplified in standard dextrose media with casamino 
acids (SD+CAA), which contains 0.5% casamino acids, 2% dextrose, 0.17% yeast nitrogen base 
without ammonium sulfate amino acids, 0.53% ammonium sulfate, 1.019% sodium dihydrogen 
phosphate, 0.856% sodium monophosphate, and supplemented with 10 U/mL penicillin, 10 
μg/mL streptomycin, and 80 μg/mL ampicillin that had been vacuum filtered through a 0.22 µm 
filter.   The library was amplified to an OD of approximately 1.5 at 30°C with shaking at 250 
RPM.  Surface expression of the library was achieved by expressing the scFv under control of a 
galactose promoter in standard galactose plus casamino acids media (SG+CAA), which 
substituted 2% galactose, 2% raffinose, and 0.1% dextrose for the dextrose in SD+CAA.  An 
initial input of 0.5 OD was amplified to approximately 1.5 OD with shaking at 250 RPM at 
20°C.  After each induction growth period, surface expression of the library was confirmed by 
flow cytometry analysis.  The monoclonal anti-HA tag antibody clone 16B12 conjugated to 
either DyLight 488 (Columbia Biosciences; Columbia, MD) or AlexaFluor 488 (Invitrogen; 
Grand Island, NY) was used to stain scFv-expressing yeast in yeast wash buffer (YWB) 
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consisting of phosphate-buffered saline (PBS), 0.5% bovine serum albumin, and 2 mM EDTA.  
The samples were run on either a Cell Lab Quanta SC (Beckman Coulter; Brea, CA) or a 
FACSCalibur (BD Biosciences; San Jose, CA) flow cytometer equipped with a 488 nm argon 
laser and 525 nm emission filter.  At least 5% partial induction of the surface library was 
confirmed and deemed sufficient for selection incubations. 
A.2.3 In Vitro Selection 
 Seven rounds of Decoy-SELEX were performed in order to obtain a scFv MRE specific 
for the LNCaP prostate cancer cell line.  The first three rounds of selection were performed by 
panning and the last four by fluorescence-activated cell sorting (FACS).  The first three rounds 
of panning-based selection were performed directly in a T75 cell culture flask.  For Round 1(+) 
selection, LNCaP cells were grown to 80-90% confluence and the media was removed.  The 
cells were gently washed with calcium- and magnesium-free phosphate-buffered saline (PBS), 
which was removed.  The cells were then incubated with 1010 yeast to ensure total representation 
of the library diversity.  The naïve yeast library was amplified as discussed previously and scFv 
surface expression was induced.  After surface expression confirmation, the library was 
suspended in 15 mL YWB.  The library was placed into the flask containing LNCaP cells and 
placed on a 37°C shaker at 25 RPM for three hours.  After incubation, yeast not bound to LNCaP 
cells were removed, and the LNCaP cells were gently washed three times with 15 mL YWB.  It 
was then noticed, however, that LNCaP cells were less than 25% confluent in the flask, likely 
due to EDTA metal chelation and subsequent cell removal.   
 To determine optimal buffer conditions, separate 90% confluent LNCaP T75 flasks were 
incubated with the following six buffers at 37°C with shaking at 25 RPM for three hours: 1) 
YWB, 2) YWB with no EDTA, 3) YWB with no EDTA and 0.1% FBS, 4) YWB with no EDTA 
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and 0.5% FBS, 5)YWB with no EDTA and 1% FBS, and 6) YWB with no EDTA and 10% FBS.  
After incubation, remaining attached cells were visually estimated and compared to before 
incubation.  Buffer 1 caused less than 25% of LNCaP to be attached, while Buffers 2-4 resulted 
in approximately 50% attachment, and Buffers 5 and 6 caused almost no detachment (90% 
confluent LNCaP cells), likely due to the FBS supplement.  Therefore, Buffer 5 was chosen as an 
appropriate incubation buffer and named yeast selection buffer (YSB).   
 After determination of an appropriate incubation buffer, the Round 1(+) incubation was 
performed as described above, however with expressing yeast suspended in YSB.  After three 
washes, 100 mL SD+CAA was added to the flask to allow for amplification of yeast bound to 
LNCaP cells.  This was grown overnight, and this enriched library was prepared for a round of 
negative selection.  For Round 1(-) selection, scFv-expressing yeast were suspended in YSB and 
incubated with rinsed HGPIN cells at 80-90% confluence for 30 minutes at 37°C with shaking at 
25 RPM.  The supernatant containing yeast-displayed scFvs not bound to HGPIN cells was 
removed and added to rinsed BPH-1 cells under the same conditions, removed again and added 
to rinsed BHPrE1 cells under the same conditions.  The serially-incubated supernatant was 
centrifuged to obtain yeast, which were suspended in SD+CAA for amplification.  Two more 
rounds of panning-based selection were performed in this manner, with decreasing incubation 
times for positive rounds and increasing incubation times for negative rounds. 
 The ensuing four rounds of selection were performed using FACS-based sorting.  For 
Round 4(+) selection, LNCaP cells grown to 80-90% confluence were fluorescently dyed with 
CFSE (Invitrogen) according to manufacturer’s instructions.  They were then dissociated from 
the flask with CellStripper reagent (Cellgro) to prevent cell surface protein digestion associated 
with trypsinization.  Cells were then suspended in YSB and counted with a Scepter equipped 
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with 60 μm sensors (Millipore; Billerica, MA).  In Round 4, all yeast were fluorescently dyed 
with Syto61 (Invitrogen) according to manufacturer’s instructions.  A total of 107 yeast were 
suspended in YSB and mixed with 106 LNCaP in a volume of approximately 2.5 mL.  They were 
mixed by inversion for 30 minutes at 37°C and placed on ice before FACS sorting.  The sample 
was then sorted with a FACSAria (BD Biosciences), with excitation at 488 nm from a sapphire 
solid state laser and 633 nm from a HeNe laser and 525 nm and 650 nm emission filters.  Events 
identified as bound yeast and LNCaP cells were collected.  In Round 4(+), there were two 
separate populations of bound cells which were collected and amplified separately.  These were 
called the ‘Hi’ and ‘Lo’ populations and kept separate through the following rounds of selection 
and subjected to the same growth and selection conditions.   
 In Round 4(-)a, for each of the Hi and Lo populations, yeast were prepared for selection 
in the same manner and incubated with 106 HGPIN cells dyed the same with inversion for 30 
minutes at 37°C in YSB.  The sample was subjected to FACS and events that indicated yeast that 
were not bound to HGPIN cells were collected and amplified.  Those were then prepared for 
selection and incubated with 106 dyed BPH-1 cells for Round 4(-)b and subjected to FACS with 
unbound yeast collected and amplified.  The enriched library was then prepared for Round 4(-)c 
and subjected to FACS after incubation with 106 dyed BHPrE1 cells.  Unbound yeast were 
collected and amplified, then prepared for selection and incubated with 1 nmol recombinant full-
length PSMA protein, which is expressed in non-prostatic normal and tumor tissue, as well as 
normal prostate cells (Silver et al. 1997) (Abnova; Walnut, CA), pre-incubated with AlexaFluor 
488-conjugated anti-GST tag antibody (Invitrogen).  The yeast which showed single 
fluorescence corresponding to Syto61 were kept and amplified. 
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 After post-Round 4 amplification, yeast from the Hi and Lo populations were prepared 
for Round 5(+) selection.  They underwent the same process as before, however they were 
fluorescently labeled with anti-HA monoclonal antibody 16B12 conjugated to AlexaFluor 647 
(Invitrogen).  This was done for the following rounds to ensure only strongly-expressing yeast 
were collected.  For Round 5(+) selection, 107 yeast were incubated with 106 LNCaP cells.  The 
yeast bound to LNCaP cells were collected, amplified, and prepared for Round 6(+) selection.  A 
total of 105 dyed LNCaP cells were used to increase stringency.  Round 6(-) was performed 
similar to Round 4(-) with the exception of antibody-labeled yeast to increase stringency.  
Unbound yeast were collected, amplified, and prepared for Round 7(+).  In that round, 103 yeast 
were used to increase stringency and select the scFvs with highest affinity.   
A.2.4 Fluorescent Imaging of scFv Library Enrichment 
 To visualize enrichment of the scFv library after 7 rounds of selection, fluorescent 
micrographs were obtained.  LNCaP cells were grown in a 6-well culture dish with number 1.5 
microscopic cover glasses to ~90% confluency and fluorescently labeled with CFSE as described 
above.  Yeast from the Round 0, post-Round 7(+) Lo, and post-Round 7(+) Hi libraries were 
cultured as described above.  Surface expression of the scFv was confirmed by antibody labeling 
and flow cytometry as described.  107 yeast were then labeled with anti-HA antibody conjugated 
to AlexaFluor 647 (Invitrogen) and incubated with LNCaP cells in 1 mL YSB in the 6-well dish.  
Cells were incubated at 37°C for 30 minutes with shaking at 25 RPM.  The supernatant was 
removed and the cells were washed three times with 2 mL YSB.  The cells were then fixed with 
10% formalin (Azer Scientific; Morgantown, PA) for 5 minutes and washed three times with 1 
mL PBS then three times with 1 mL double-distilled water.  Cover slips were dried and flipped 
onto a microscope slide prepared with 20 uL Fluorogel (Electron Microscopy Sciences; Hatfield, 
99 
 
PA), and dried.  Mounted cells were imaged on a Zeiss LSM 510 Confocal Microscope (Zeiss; 
Thornwood, NY) using an Argon laser at 488 nm and a HeNe laser at 688 nm for excitation with 
emission filters at 505-530 nm band pass and 650 nm.  Images were processed with Zeiss LSM 
Image Browser (Zeiss). 
A.2.5 Sequencing of scFv Library 
 A representative sample of scFv-genes from the naïve library (Round 0) was sequenced 
to determine diversity of the library.  Additionally, this was completed for the enriched post-
Round 2(-) and post-Round 3(-) libraries.  It was also performed for each of the Hi and Lo 
populations following Round 4(-), Round 6(-) and Round 7(+) selections.  To do this, yeast 
amplified from the previous round of selection were plated onto 2% agar plates containing 1% 
yeast extract, 2% peptone, and 2% dextrose (YPD).  Yeast were grown for 36-48 hours at 30°C, 
and individual colonies were chosen for polymerase chain reaction (PCR) amplification.   
 Yeast colonies were picked and placed into double distilled water and boiled, which 
served as template for the PCR reaction.  The reaction ingredients were as follows:400 nM 
forward (5’-GTACGAGCTAAAAGTACAGTG-3’) and reverse (5’-
TAGATACCCATACGACGTTC-3’) pPNL6 primers (Eurofins MWG Operon), 250 µM 
deoxynucleotide triphosphates, 5% dimethyl sulfoxide, 1X Phusion Reaction Buffer (New 
England Biolabs, Ipswich, MA), 2 units Phusion High-Fidelity DNA polymerase (New England 
Biolabs), and double distilled water to 100 μL.  Reactions conditions were: initial denaturation at 
98°C for 30 seconds; 35 cycles of 98°C for 10 seconds, 50°C for 30 seconds, and 72°C for 30 
seconds; and final extension at 72°C for 10 minutes.  Results were analyzed using agarose gel 
electrophoresis and those PCRs that contained bands corresponding to the scFv gene were 
prepared for sequencing.  They were purified using a PCR purification kit (IBI Scientific; Peosta, 
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IA) and sent for DNA sequencing (Eurofins MWG Operon; Huntsville, AL) using both the 
forward and reverse pPNL6 primers.  In total, at least 30 sequences were obtained for each 
enriched library noted above.  Analysis was then performed by translating the DNA sequence to 
protein using the ExPASy translate tool (Swiss Institute of Bioinformatics; 
http://web.expasy.org/translate/).  Hemagluttanin, c-Myc, and linker protein tag sequences, 
landmarks of the scFv expression scaffold, were identified to ensure sequence quality (Boder and 
Wittrup 1997).  Sequences were compared for similarities and duplicates within an enriched 
library were identified to determine diversity of the library. 
A.2.6 Secretion and Purification of Selected scFvs 
 From the Rounds 6(-) and 7(+) sequences, three scFvs were chosen for further study due 
to their abundance in the enriched libraries: HiR6.8, HiR7.6, and HiR7.8.  Sequences were PCR 
amplified with the same ingredients and under the same conditions as above; however pPNL9 
primers were used.  For full length scFv sequences (HiR6.8), the forward pPNL9 (5’-
GACGTTCCAGACTACGCTGGTGGTGGTGGTTCTGCTA-3’) and reverse pPNL9 (5’-
GGGTTAGGGATAGGCTTACCCTGTTGTTCTAGAATTCCG-3’) were used.  For truncated 
scFv sequences (HiR7.6 and HiR7.8) containing only the heavy chain, forward pPNL9 and 
modified reverse pPNL9 (5’- 
GGGTTAGGGATAGGCTTACCGAACTCTGAAGAGACGGTGACC-3’) were used.  The 
PCR product was analyzed by agarose gel electrophoresis and the desired scFv-encoding gene 
was excised from the gel.  DNA was purified from the gel using the GFX gel purification kit (GE 




 To express and secrete the scFv, the encoding gene was cloned into the pPNL9 plasmid 
which was transformed into the YVH10 strain yeast, both generous gifts from Dr. Dane Wittrup 
(Massachusetts Institute of Technology).  Prior to cloning, the pPNL9 plasmid was double 
digested with the restriction enzymes NotI and SfiI (New England Biolabs) and analyzed by 
agarose gel electrophoresis.  The plasmid was prepared for further studies by phenol/chloroform 
extraction and ethanol precipitation.  Transformation was performed by gap repair cloning and 
the LiAc TRAFO method as previously described (Gietz and Woods 2002).  Briefly, YVH10 
yeast with no plasmid were grown in YPD broth.  A fresh sample was taken and centrifuged, 
then resuspended in the following: 67% of 50% polyethylene glycol 3350, 0.1 M lithium acetate, 
13.9% of 2 mg/mL boiled carrier DNA (salmon testes genomic DNA; Sigma), approximately 1 
μg purified pPNL9-amplified scFv DNA, and approximately 0.3 μg double-digested pPNL9 
plasmid, with water to 360 μL.  The yeast were incubated at 42°C for 1.5 hours, centrifuged, and 
suspended in water.  They were then plated on selective SD+CAA agar with 0.8% tryptophan 
(Trp) and grown at 30°C for 48-96 hours until individual colonies formed.   
 Individual colonies were chosen and subjected to colony PCR amplification as previously 
described, with the appropriate pPNL9 primer set used.  The purified PCR product was sent for 
DNA sequencing to confirm the insert.  The colony was then amplified in selective 
SD+CAA+Trp media overnight at 30°C with shaking at 250 RPM.  Approximately 5 X 108 yeast 
were then centrifuged and suspended in 50 mL expression media containing 1% yeast extract, 
2% peptone, 2% galactose, 2% raffinose, and 0.1% dextrose, plus antibiotics as listed above 
(YPG/R).  Yeast were grown for approximately 72 hours with shaking at 250 RPM at 20°C for 
secretion of scFv.   
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 After scFv secretion, supernatant was removed from the yeast by centrifugation.  The 
supernatant was concentrated with a 9 kDa centrifugal filter (Pierce).  The concentrated scFv 
solution was then brought to a volume of 10 mL with PBS, 0.5 M NaCl, and 0.05% Tween 20.  
Then, 200 μL Ni-NTA agarose resin (Qiagen; Valencia, CA) was added and mixed with 
inversion at 4°C for 2 hours for purification of 6-His tagged scFvs.  The mixture was centrifuged 
and supernatant removed and washed three times with 10 mL PBS, 0.5 M NaCl, and 0.05% 
Tween 20 solution.  The scFv was then eluted from the agarose resin three times with 250 μL of 
200 mM imidazole in PBS.  Pre-incubation, wash, and elution fractions were then concentrated 
using a 3 kDa molecular weight centrifugal filter (Pierce).   
 Concentrated fractions were then analyzed using sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE).  Samples were mixed with loading dye, denatured and loaded 
into a 4-20% Tris-HEPES gel.  Samples were run and the gel was stained with Coomassie blue 
staining buffer.  The gel was imaged, in which proper secretion and purification was confirmed 
by obtaining bands of the appropriate size for each scFv.  Remaining elution fractions were 
combined, with extra imidazole removed with 3 kDa centrifugal columns.  The concentration of 
the scFv was determined using spectroscopy with a NanoDrop (Thermo Scientific; West Palm 
Beach, FL).  The scFv was then diluted to a working concentration of 10 μM in PBS. 
A.2.7 Affinity Binding Assays with scFvs 
 In order to determine the binding affinity of each secreted scFv with the LNCaP cell line, 
saturation binding assays were performed with flow cytometry with few modifications to 
previous work (Benedict et al. 1997; Boder et al. 2000).  LNCaP cells were grown to 80-90% 
confluency and removed from the flask with CellStripper reagent.  The cells were counted with a 
Scepter equipped with 60 μm sensors.  Then, 2 X 105 cells were placed into a 500 μL total 
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volume of YSB.  LNCaP cells incubated with no antibody served as a negative fluorescent 
control, and LNCaP cells incubated with 1 μL anti-PSMA antibody conjugated to AlexaFluor 
488 (BioLegend; San Diego, CA) served as a positive fluorescent control.  For saturation binding 
assays, the appropriate amount of each scFv was incubated on ice for 30 minutes with 2 μL of 
the monoclonal anti-HA antibody clone 16B12 conjugated to DyLight 488 (Columbia 
Biosciences).  Concentrations of 0, 1, 10, 100, 1000, 10000, 50000, 100000, 150000, 200000 pM 
of the scFv were used. The pre-incubated scFv and secondary antibody were mixed with LNCaP 
cells and placed on a rotisserie at 37°C for 30 minutes.  After this period, the cells were 
centrifuged for 7 minutes at 300xg at 4°C.  The supernatant was removed and the cells were 
resuspended in 500 μL YSB.   
    Samples were run on a FACSCalibur (BD Biosciences) as previously described.  The 
mean fluorescence intensity (MFI) for each sample was recorded.  The MFI for the 0 pM 
incubation, which had only the secondary fluorescent antibody, served as background 
fluorescence and was subtracted from the MFI of each incubation.  These data were graphed 
using Origin 8 software (OriginLab Corporation; Northampton, MA).  The data were fit with a 
nonlinear regression model of single-event binding given by the equation, Y=((Bmax*X)/(Kd + 
X)) + NS*X, where Bmax is maximum binding, Kd is the dissociation constant, and NS is 
nonspecific binding.  Binding assays for HiR6.8 and HiR7.8 were performed in triplicate, with 
average dissociation constants calculated and standard errors derived from the equation.  Binding 
assays for HiR7.6 will be performed in the future in triplicate. 
A.2.8 Specificity Binding Assays of scFvs  
In order to determine the specificity of MRE binding, cross-binding assays were 
performed with the cell lines used as negative targets in the selection.  LNCaP, HGPIN, BPH-1, 
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and BHPrE1 cells were grown to 80-90% confluency and removed from the flask with 
CellStripper reagent.  Cells were then counted with a Scepter using 60 μm sensors and 2 X 105 
cells were placed into a final volume of 500 μL YSB.  For each cell line, cells with no antibody 
served as a negative control.  Concentrations of 0 or 100000 pM scFv were incubated with the 
secondary anti-HA AlexaFluor 488 antibody for 30 minutes on ice.  Each of these were then 
mixed with each cell line and incubated on a rotisserie at 37°C for 30 minutes.  The cells were 
then centrifuged, the supernatant removed, and they were resuspended in 500 μL YSB.  Each 
sample was then run on a FACSCalibur as previously described and the MFI recorded.  The MFI 
of the 0 pM incubation, which had only the secondary fluorescent antibody, served as 
background fluorescent labeling and was subtracted from the 100000 pM incubation.  Data were 
normalized to LNCaP binding, which was set to 100%, and graphed to show comparative 
binding between the cell lines.  HiR6.8 and HiR7.8 assays have been performed in triplicate, 
with average values calculated and Student's T-tests performed to determine statistical 
significance.  HiR7.6 will be assayed in the future in triplicate. 
 In order to determine binding to other prostatic cell lines used not used in the selection, 
cross-binding assays were performed.  LNCaP, the androgen insensitive prostate cancer cell lines 
DU-145 and PC-3, and the normal prostatic cell lines RWPE-1 and NHPrE1 were used for this 
experiment.  The cells were prepared as noted for the other cross-binding assays and incubated 
with the scFv as described above.  Samples were run on a FACSCalibur and the MFI was 
normalized and graphed as noted.  HiR6.8 and HiR7.8 have been performed in triplicated, with 
average values calculated and Student's T-tests performed to determine statistical significance.  




A.2.9 Fluorescent Imaging of scFv Binding 
 In order to visualize binding of each scFv, fluorescent images were taken.  LNCaP cells 
were grown in a 6-well culture dish with number 1.5 microscopic cover glasses to ~90% 
confluency.  For each scFv, a 100 nM concentration was pre-incubated with anti-HA antibody 
conjugated to DyLight 488 as described for binding assays, in addition to LNCaP cells with anti-
PSMA antibody, and those with secondary antibody only in a total volume of 500 µL YSB.  
Cells were incubated at 37°C for 30 minutes with shaking at 25 RPM.  The supernatant was 
removed and the cells were washed once with 2 mL YSB.  The cells were then fixed with 10% 
formalin (Azer Scientific; Morgantown, PA) for 5 minutes and washed three times with 1 mL 
PBS then three times with 1 mL double-distilled water.  Cover slips were dried and flipped onto 
a microscope slide prepared with 20 uL Fluorogel (Electron Microscopy Sciences; Hatfield, PA), 
and dried.  Mounted cells were imaged on a Zeiss AxioImager Z2 Fluorescent Microscope 
(Zeiss; Thornwood, NY) using an Argon laser at 488 nm for excitation with a band pass 
emission filter at 505-530 nm. 
A.3 Results and Discussion 
A.3.1 Selection of MREs 
 In order to obtain prostate cancer cell-specific MREs, seven rounds of the Decoy-SELEX 
process were completed.  Sequencing of the scFv-encoding plasmid in the initial naïve library, as 
well as after Round 2 and Round 3 of panning selection, was performed.  Out of at least 30 
sequences obtained, there were no duplicate sequences in any library.  Additionally, there were 
no duplicates between the libraries.  This suggests that all three libraries were highly diverse, 
with no particular sequence having been selected for. 
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 After three rounds, FACS-based selections were performed.  In Round 4 (+), there were 
two separate populations of yeast binding to LNCaP cells.  One was characterized by having 
relatively high Syto61 (yeast) fluorescence with low CFSE (LNCaP) fluorescence, and this was 
designated the ‘Hi’ population.  The other was characterized by having relatively low Syto61 
(yeast) fluorescence with high CFSE (LNCaP) fluorescence, and was designed the ‘Lo’ 
population.  These were sorted separately and kept separate through the remaining rounds of 
selection, while each was subjected to identical growth and selection conditions.   
 After the negative selections in Round 4, sequencing of the scFv-encoding genes in the 
library revealed duplicate sequences within individual libraries.  The Lo population was 
comprised of 29% HiR7.8 and between 3% and 13% of 13 other molecules (Figure A.2).   
 
Figure A.2. Enrichment of the Lo and Hi yeast-displayed scFv populations after FACS-
based selection rounds.  Evolution of library diversity after Round 4, the first round of FACS-
based selection, Round 6, and Round 7.  Lo population is the top row the Hi population on the 
bottom.  The names of the sequences represented by each color in the pie charts are shown to the 




Interestingly, HiR7.6 and HiR6.8 were not present in the Lo population.  In the Hi population, 
however, HiR7.6 comprised 52% of the population, while HiR6.8 was 26%.  One other scFv was 
3% and a final molecule was 19%.  Interestingly, HiR7.8 did not appear in the Round 4 Hi 
population.  It is also of note that HiR7.6 and HiR7.8 did not appear in any previous library 
sequencing, however HiR6.8 did appear once in the Round 3 library. 
 Following the sixth round of selection, the Lo and Hi libraries were sequenced.  In the Lo 
population, 30 out of 30 (100%) of the sequenced molecules were HiR7.8, and there were no 
longer any other detectable scFvs in the library (Figure A.2).  This suggests that, within this 
population, HiR7.8 was strongly enriched for in Rounds 5 and 6 of selection.  In the Hi 
population, 77% of the library was HiR7.6 while 3% was HiR6.8.  Interestingly, HiR7.8 now 
comprised 20% of the library, and no other molecules were present.  This suggests that HiR7.6  
 
Figure A.3. Fluorescent micrographs of yeast binding enrichment. Confocal microscope 
images at 200X of LNCaP cells (green) incubated different scFv-displaying yeast libraries. (a) 
LNCaP incubated with Round 0 library. (b) LNCaP incubated with Round 7(+)Lo library. (c) 
LNCaP incubated with Round 7(+) Hi library.  Images show enrichment of yeast library through 




outcompeted HiR6.8 within this population.  It also suggests that HiR7.8 was present previously 
in the library, but not detected, and had outcompeted HiR6.8.   
 Following a very stringent Round 7(+) selection, using 10,000 fewer target cells than 
yeast, and 1,000 times fewer LNCaP that Round 6(+), sequencing further revealed the scFvs 
present in the library.  In the Lo population, 100% of the molecules present were again HiR7.8 
(Figure A.2).  While there may have been other scFvs in the library, it is unlikely after two 
consecutive rounds of not detecting any besides HiR7.8.  In the Hi population, HiR6.8 was no 
longer detected, while HiR7.6 was now just 16% of the library.  HiR7.8 comprised 84% of the 
library, suggesting it strongly outcompeted HiR7.6.  It is possible that if more rounds of selection 
were completed under more stringent conditions, HiR7.8 would totally comprise the Hi 
population as well.  
 Visualization of library enrichment for scFvs binding to LNCaP cells was performed.  
This provided evidence that few or none of the molecules in the Round 0 library were binding to 
LNCaP cells (Figure A.3).  However, after seven rounds of selection, both the Lo and Hi 
populations were strongly specific for LNCaP cells (Figure A.3).  This, along with the sequence 
evolution, validates the sequence enrichment capabilities of the novel Decoy-SELEX process.  
From this obvious enrichment through seven rounds of Decoy-SELEX, HiR7.8 was chosen as 
the most likely prostate cancer cell-specific MRE and underwent further characterization.  
However, to determine why it outcompeted HiR6.8 and HiR7.6, those molecules were also 
chosen for further characterization.  It is also important to note that HiR6.8 is a full-length scFv, 
comprising both a heavy and light chain, with a predicted molecular weight of approximately 
30.6 kDa for the scFv itself (Table A.2).  HiR7.8 and HiR7.6, however, only contain a heavy 
chain, as they are truncated just before the chain linker.  They have a predicted molecular weight 
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of approximately 16.0 and 15.6 kDa, respectively, and have 81% sequence identity and 86% 
sequence similarity.  Truncated sequences containing only heavy chains were found in 
sequencing of the naïve library in the original published description (Feldhaus et al. 2003).  This 
may be relevant in vivo, as it has been shown that smaller scFvs have greater tumor penetration 
ability than larger antibodies (Colcher et al. 1998). 





















*Underlined amino acids represent the heavy chain. Double underlined amino acids represent the 
light chain.  HiR7.6 and HiR7.8 do not contain a light chain. Non-underlined amino acids 
represent scFv structural elements. 
 
A.3.2 Affinity Binding Assays of scFvs 
 Once HiR6.8, HiR7.6, and HiR7.8 were identified for further characterization, each was 
cloned into a secretion vector, expressed, and purified.  HiR6.8 and HiR7.8 were used in 
fluorescent saturation binding assays with LNCaP cells as described above, plotted, and fit with 
nonlinear regression analysis (Figure A.4).  HiR6.8 exhibited an equilibrium dissociation 
constant (Kd) of 33.19 +/- 22.18 nM (Table A.3).  The binding affinity of HiR7.6 for LNCaP 
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cells will be assayed in the future.  The binding affinity of HiR7.8 is 27.28 +/- 15.85 nM.  The 
slightly higher affinity of HiR7.8 for LNCaP cells may be a partial explanation as 
 
Figure A.4. Plot of fluorescent equilibrium binding assay of HiR6.8 and LNCaP cells.  
Calculated dissociation constant (Kd) of this assay is 30.52 +/- 27.08 nM. 
 
Table A.3. Equilibrium dissociation constant (Kd) of prostate cancer cell MREs. 
HiR6.8 HiR7.6 HiR7.8 
33.19 +/- 22.18 nM * 27.28 +/- 15.85 nM 
Data are reported as Kd +/- Standard Error as given by the binding equation. “*” denotes that the 
data are yet to be acquired. 
 
to why it was enriched for throughout Decoy-SELEX.  The dissociation constants for each of 
these scFvs is in the low-nanomolar range, which is similar to previous reports of scFvs isolated 
from the selection process (Schier et al. 1996; Benedict et al. 1997; Böldicke et al. 2001).  More 
importantly, it is in a range that has previously been shown to confer strong pharmacokinetic 
properties (Adams et al. 1998; Jackson et al. 1998).  It is possible that further mutagenesis and 
screening may select for scFvs with higher affinity for the cell surface target (Schier et al. 1996; 
Boder et al. 2000).   
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 Binding of both HiR6.8 and HiR7.8 to LNCaP cells is further evidenced by fluorescent 
micrographic analysis.  Binding of each scFv is clear when pre-incubated with a secondary 
fluorescent antibody then with LNCaP cells and imaged for fluorescent staining (Figure A.5).  
Fluorescence is much brighter than LNCaP cells incubated with fluorescent secondary-only 
control.  Interestingly, both antibodies have a semi-circular or horseshoe-like staining pattern for 
each cell.  Therefore, fluorescence may be visualized in the cytosol surrounding the nucleus.  It 
may be possible that the images represent cellular uptake of the scFv-secondary antibody 
complex.  This has previously shown to be possible and even likely with scFvs alone or in 
complex with other molecules (Gao et al. 2003; Nielsen et al. 2006; He et al. 2010).  This may 
have an important role in the clinical application of these MREs.  The potential ability to use 
these scFvs as therapeutic targeting agents in the form of antibody-drug conjugates (ADCs) is 
enhanced by scFv internalization (Schrama et al. 2006).  Potential uptake of the scFv by LNCaP 
cells may be explored in future studies.  First, confirming cytoplasmic staining using a nuclear 
dye such as DAPI would be useful.  This could then be furthered by subcellular fractionation 
experiments.  These are potentially interesting further directions stemming from fluorescent 
imaging of scFv binding. 
A.3.3 Specificity Binding Assays of scFvs 
 Purified HiR6.8 and HiR7.8 were each assayed for their ability to bind to cell lines other 
than LNCaP.  HiR7.6 will be assayed in the future for its binding to other cell lines.  These 
included the negative targets in the selection process, HGPIN, BPH-1, and BHPrE1 (Figure A.6 
a and Figure A.7a).  They also included androgen-independent prostate cancer cell lines DU-145 
and PC-3 as well as normal prostate epithelium cell lines RWPE-1 and NHPrE1 (Figure A.6b 




Figure A.5. Micrographs of scFv binding to LNCaP cells.  Each panel shows micrographs at 
630X of fluorescence from AlexaFluor 488 in green (left) and combined fluorescent plus 
brightfield image (right). (a) LNCaP cells incubated with only secondary antibody. (b) LNCaP 
cells incubated with HiR6.8 plus secondary fluorescent antibody. (c) LNCaP cells incubated with 
HiR7.8 plus secondary fluorescent antibody. 
 
 From these experiments, it is clear that HiR6.8 binds to all three negative cell lines as 
well as the other two androgen-dependent prostate cancer cell lines assayed.  Binding to many of 
these lines was as good as or better than binding to LNCaP cells.  This is a likely explanation as 
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to why HiR6.8 was eventually eliminated from both populations, in spite of its low dissociation 
constant (Figure A.6).  HiR7.8, however, showed excellent selectivity for LNCaP cells (Figure 
A.7).  Binding to HGPIN, BPH-1, and BHPrE1 cells all was much less than to LNCaP, in fact 
they were negative.  This means that the MFI of cells incubated with 100000 pM HiR7.8 and 
secondary fluorescent antibody was less fluorescent than cells incubated with secondary 
fluorescent antibody only.  This can be explained by pre-incubation and binding of the scFv with 
the secondary antibody, causing background non-specific binding of the secondary antibody to 
the cells to be less.  Therefore, the negative relative MFI suggests that the antibody is present and 
binding to the secondary antibody, but not to the cells.  Additionally, binding to the four cell 
lines not used in the selection was either negative or much less relative to binding to LNCaP 
cells.  In sum, this suggests that HiR7.8 is highly specific to LNCaP cells and therefore useful in 
both the therapeutic targeting and disease detection of prostate cancer.   
 Biologically, the selectivity of HiR7.8 for LNCaP cells is important.  There is a complete 
absence of binding to all benign cell lines studied, whether they represent normal prostatic cells, 
BPH, or PIN.  This suggests that the cell surface molecule HiR7.8 is binding to is not displayed 
on the surface of benign prostatic cells.  This is supported by previous studies that have 
identified many genes differentially expressed between the benign conditions represented here 
and prostate cancer cells (Chakrabarti et al. 2002; Zeng et al. 2004; Chen et al. 2011).   
 Additionally, there is no binding to the androgen-independent prostate cancer cell lines 
DU-145 or PC-3.  This leads to the conclusion that the cell surface antigen is displayed in the 
earlier, androgen-dependent stage of prostate cancer.  This is possible considering previous 





Figure A.6. Cross-binding of HiR6.8 to negative targets and other cell lines. Binding of 
HiR6.8 to (a) each cell line used in the selection or (b) or prostatic cell lines. Data are normalized 




Figure A.7. Cross-Binding of HiR7.8 to negative targets and other cell lines. Binding of 
HiR7.8 to (a) each cell line used in the selection or (b) other prostatic cell lines. Data are 
normalized to LNCaP binding at 100% for comparison. "*" represents p <  0.05, "**" represents 
p < 0.01, "***" represents p < 0.001. 
 
dependent to independent disease progression, many of which are downregulated (Amler et al. 
2000; Karan et al. 2002; Chen et al. 2006).  In fact, downregulation of expression levels from 
LNCaP to both DU-145 and PC-3 cells has been found before (Yang et al. 1998; Aalinkeel et al. 
2004; Okamura et al. 2008; Liu et al. 2009)  It is unclear if HiR7.8 would bind to other 
androgen-dependent prostate cancer cells, or cells earlier in the progression of the disease, 
however future work may determine this.  Determining binding will be aided by identifying the 
exact cell surface molecule to which HiR7.8 is binding, as has been done before with other 
MREs (Robert et al. 2006; Rérole et al. 2011).  This type of work has even identified novel cell 





2008).  It is therefore possible that this work not only created a novel targeting agent, but also 
identified a novel target. 
 HiR6.8, however, is not specific for any one type of cell.  This may be because it is 
binding to some widely-expressed prostate-specific gene such as PSMA (Wright et al. 1995), or 
because it is binding to any one of a number of common cell surface molecules.  Determining the 
cell surface antigen for HiR6.8 will be important as it may be useful as a broad marker of 
prostatic cells similar to PSCA or p63 (Signoretti et al. 2000; Tran et al. 2002), or it may be 
useful in marking a particular cell surface antigen such as previous scFvs for ICAM-1 (Conrad et 
al. 2009).  Therefore, in spite of its spectrum of binding, the high affinity of HiR6.8 for its cell 
surface target will allow the scFv to be useful for future applications, even if it is not useful in 
the specific targeting of prostate cancer cells. 
 The high affinity and specificity of HiR7.8 for LNCaP prostate cancer cells suggest it has 
potential in future therapeutic and diagnostic applications in prostate cancer.  It is unclear 
whether it will bind to prostate cancer tissue, however it is likely that it will based on binding 
specificity and affinity similar to previously-selected MREs (Ni et al. 2011).  This will rely on 
surface expression of its cognate antigen.  The selective scFv will likely be useful for drug 
delivery as part of an antibody-drug conjugate (Senter 2009), for chemotherapeutic delivery 
(Sievers and Linenberger 2001), for radiotherapy delivery (Regino et al. 2009), or possibly even 
as a therapeutic by itself, depending on the function of the cell surface molecule (Stebbing et al. 
2000).  Additionally, it will likely have use in specific diagnosis of prostate cancer, whether 
coupled with an in vivo imaging agent (Elsässer-Beile et al. 2009; Veiseh et al. 2010), a capture 
agent for circulating tumor cells (Nagrath et al. 2007), or as a tissue stain after biopsy (Johnston 
et al. 1986).  Finally, identification of the cell surface markers which these MREs bind to may 
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possibly identify novel proteins, new functions, or expression patterns that aid in treatment and 
diagnosis of prostate cancer. 
A.4 Conclusions 
 This work has selected a MRE with high affinity for the androgen-dependent prostate 
cancer cell line LNCaP.  Furthermore, the selected MRE has a high selectivity for the androgen-
dependent prostate cancer cell line, and not for benign prostatic cell lines or for androgen-
independent prostate cancer cells.  These characteristics will allow the selected scFv to be useful 
for both therapeutic and diagnostic applications in the clinical treatment of prostate cancer.  With 
targeted therapeutics and more specific diagnostics, it is possible that the disease burden of the 
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 Malathion is the mostly commonly-used organophosphate pesticide in the United States.  
Approximately 16.7 million pounds are used annually, with 12 million pounds being applied to 
crops (Wilson et al. 2003).  Many other uses include in sewage systems, plant nurseries, home 
use, and recreational land maintenance (Wilson et al. 2003).  Three major historical applications 
in the U.S. were Boll Weevil eradication, Medfly suppression, and mosquito suppression 
(Newhart 2006).  Its widespread use portends the benefits of malathion usage. 
 Due to its many uses, malathion has become an environmental contaminant with multiple 
routes of exposure.  Aerial applications often drift to non-target locations, including waterways, 
up to 200 meters away (LeNoir et al. 1999; Newhart 2006).  This method can also lead to 
volatilization of up to 22.6% of that applied, leading to reduced air quality levels and vaporized 
contamination spread potentially over large distances (Turner et al. 1991; LeNoir et al. 1999; 
Ferrari et al. 2003).  After one large application, malathion was found in freshwater ponds at 
levels up to 49.4 μg/L (Segawa et al. 1991).  Additionally, runoff due to storms after application 
has led to levels up to 787.1 μg/L being found (Ando et al. 1996).  Detection in groundwater and 
surface water has also occurred at levels up to 6 µg/L during normal conditions (Newhart 2006).  
In the state of West Virginia, malathion has been found at levels that exceed guidelines for 
environmental contamination (Ferrari and Assessment 1997; Ator 1998).  Furthermore, one 
study found that 33.7% of corn grain,  27.8% of cultivated and frozen blueberries, 24.6% of 
strawberries, and 19.3% of celery samples on the market tested had detectable levels of 
malathion (USDA 2009).  Clearly, release of malathion into the environment and its interaction 
with humans and other organisms is occurring. 
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 The presence of malathion in the environment is of particular concern to human health.  
The U.S. Environmental Protection Agency categorizes the pesticide as having "suggestive 
evidence of carcinogenic potential" (USEPA 2012).  This is supported by studies showing 
induction of mammary epithelial cell proliferation and other carcinogenic effects by malathion 
through acetylcholinesterase inhibition in rats (Cabello et al. 2001).  Additionally, there is a 
55%-72% increase in the odds of Attention-Deficit/Hyperactivity Disorder (ADHD) being 
diagnosed in children that have ten-fold higher malathion exposure levels (Bouchard et al. 2010).  
Higher concentrations have also been found to have cytotoxic and genotoxic effects on human 
and other mammalian cells (Giri et al. 2002; Moore et al. 2010).  These effects suggest that 
increased levels of environmental malathion concentrations are detrimental from a public health 
perspective. 
 Ecologically, non-target effects of malathion also have severe negative impacts.  To 
various fish species, malathion is highly toxic, with LC50 values as low as 0.1 µg/L for brown 
trout (USGA 2000).  Many aquatic invertebrates are also highly susceptible to exposure, with 
LC50 values below environmentally relevant levels, down to 0.5 µg/L (USEPA 2006).  It also 
has other negative effects at sublethal concentrations to a variety of aquatic species (Key et al. 
1998; Beauvais et al. 2000; Nguyen and Janssen 2001).  Furthermore, the pesticide has been 
shown to have negative survival effects at environmentally relevant concentrations on tadpoles 
and frogs (Fordham et al. 2001), small mammals (Newhart 2006), reptiles (Holem et al. 2008), 
and non-target beneficial insects (Gary and Mussen 1984).  It is therefore important that 
individual species and entire ecosystems are protected from malathion exposure. 
 Currently, detection of malathion in biological and environmental samples is mostly 
achieved using gas chromatography (GC).  While this method is sensitive and methods for 
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malathion detection have been improved upon, it is also time- and labor-intensive and requires 
expensive and expertly-used equipment (Zweig and Devine 1969; Fournier et al. 1978; Wilson et 
al. 2003).  Other methods of malathion exposure include monitoring blood cholinesterase activity 
or excretion of metabolites (Fenske and Leffingwell 1989; Wilson et al. 2003).  There have also 
been antibody assays developed for malathion detection, however these antibodies have not been 
assayed for their affinity or only assayed for cross-reactivity to a few of malathion's major 
chemically-related metabolites (Nishi et al. 2003; Brun et al. 2005; Vera-Avila et al. 2005).  As 
the antibodies were not identified for their selectivity, it is likely that they bind to major 
metabolites.  This is similar to an antibody which binds to a whole class of molecules similar to 
malathion (Yan et al. 2009).  Therefore, it is necessary to identify a molecule that has been 
identified for its high affinity and specificity for malathion and not its metabolites. 
 Identification of such a molecule can be accomplished using the Selective Evolution of 
Ligands by EXponential Enrichment (SELEX).  Binding molecules identified with this process 
are termed Molecular Recognition Elements (MREs).  This in vitro selection process was 
originally described by two separate laboratories and MREs are selected from a large library 
(109-1015) of different molecules (Ellington and Szostak 1990; Tuerk and Gold 1990).  This 
library is incubated with the target of interest, and those molecules that do not bind to it are 
removed.  Those that do are amplified and can be subjected to negative selections.  In those, 
molecules that do not to the negative targets are amplified.  This iterative process continues with 
increasingly stringent selection conditions until one or a few highly selective molecules with 
high affinities are identified.  A novel variation of this process developed in our laboratory is 
termed Decoy-SELEX.  Using this method, the library is enriched for the target of interest.  
However, the focus of the selection is on what the MRE should not bind to utilizing stringent 
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negative selections.  Therefore, the Decoy-SELEX method is ideal for identifying MREs with 
both high affinity and selectivity for the target of interest. 
 In this work, the Decoy-SELEX method was utilized to identify an MRE for the pesticide 
malathion.  The selection scheme was designed to enriched a single-stranded DNA (ssDNA) 
library for molecules which bind to malathion.  Those molecules which bound to major 
metabolites of malathion were removed.  Those metabolites included dimethyl thiophosphate 
(DMTP), dimethyl dithiophosphate (DMDTP), malathion dicarboxylic acid (MDA), and 
malaoxon (Buratti et al. 2005).  The MRE was also designed to not bind to other pesticides found 
in similar amounts and environments as malathion including propanil (Köck et al. 2010), 2,4-D 
acid (Baker et al. 2000), and atrazine (McCarthy and Fuiman 2008).  Additionally, bovine serum 
albumin (BSA) was used as a negative target as a model for large, globular proteins.  The 
selected MRE may be used as a sensor in a rapid, field-deployable detection device (Soh et al. 
2009; Yang et al. 2010; Lin et al. 2011). 
B.2 Methods 
B.2.1 Decoy-SELEX for Malathion-Specific MREs 
 Twelve rounds of the Decoy-SELEX process were performed to obtain a MRE specific 
for the pesticide malathion (Figure B.1).  A ssDNA library with a diversity of 1015 molecules 
was enriched for those that bound to malathion and not the negative targets of selection (Figure 
B.2).  The library was designed within our laboratory and designated RMW.N34.  The ssDNA 
library was commercially synthesized and consists of two 23 base constant regions for 
polymerase chain reaction (PCR) amplification that flank a 34 base random region (Eurofins 
MWG Operon; Huntsville, AL).   
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 The malathion derivative malathion monocarboxylic acid (Figure B.2b) was covalently 
biotinylated using EDC-NHS chemistry.  It was reacted with 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide (EDC) (ThermoScientific; Rockford, IL) and then incubated 
with Amine-PEG2-Biotin (Pierce; Rockford, IL) according to manufacturer's instructions.  The 
biotinylated derivative was bound to streptavidin-coated magnetic beads (New England Biolabs; 
Ipswich, MA) and washed to provide the immobilized target (IT).   
 
Figure B.1. Decoy-SELEX scheme for selection of a malathion MRE. 1015 different ssDNA 
molecules were incubated with malathion.  Those that bound were amplified and subjected to 
closely-related targets.  Those do not bind those were amplified and re-subjected to malathion 
under more stringent conditions.  This process continued for 12 rounds. 
 
 For Round 1(+) selection, the ssDNA library was incubated with 50 µL IT in a total of 
500 µL selection buffer containing 100 mM sodium chloride, 20 mM Tris-HCl, and 2 mM 
magnesium chloride (1X selection buffer; SB).  The mixture was incubated at room temperature 
on a rotisserie for 48 hours.  The IT with bound ssDNA was removed from the solution by 




Figure B.2. Chemical structures of molecules used in selection of a malathion-specific 
MRE.  (a) Structure of the target of selection, malathion. (b) Structure of malathion 
monocarboxylic acid, a malathion derivative used in magnetic bead immobilization. (c) and (d) 
Structures of dimethyl thiophosphate and dimethyl dithiophosphate used as negative targets in 
Round 8(-). (e) Chemical structure of malathion dicarboxylic acid, used in Round 9(-) selection. 
(f) Structure of malaoxon, used in Round 10(-) selection. (g), (h), and (i) Structures of propanil, 
2,4-D acid, and atrazine, used successively in Round 7(-) of selection. (j) Ribbon structure of 
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bovine serum albumin (BSA) used as a negative target in Round 11(-) of selection (Bujacz 
2012). 
 
as a template for PCR amplification of ssDNA bound to the IT.  PCR amplification was 
performed with the following reaction ingredients: enriched ssDNA library, 400 nM forward and 
biotinylated reverse RMW.N34 primers (Eurofins MWG Operon) (forward: 5’-
TGTACCGTCTGAGCGATTCGTAC-3’, biotinylated reverse: 5’-Biotin- 
GCACTCCTTAACACTGACTGGCT -3’), 250 µM deoxynucleotide triphosphates, 1X GoTaq 
Reaction Buffer (Promega; Madison, WI), 3.5 units Taq, and pure water to 100 µL.  Thermal 
cycling conditions were: initial denaturation of 95°C for 5 minutes; cycling at 95°C for 1 minute, 
63°C for 45 seconds, and 72°C for 1 minute; and final extension of 72°C for 7 minutes.  
Amplification for carrying the library to the next round of selection was performed using either a 
4 mL or a 2 mL total volume PCR, which respectively preceded positive and negative selection 
rounds. 
 The amplified DNA was then purified by agarose gel electrophoresis using the GFX PCR 
purification kit (GE Healthcare; Piscataway, NJ).  Recovered dsDNA was then incubated with 
streptavidin agarose resin (Pierce) for separation of single strands.  The biotinylated reverse 
primer used in PCR amplification allowed for binding of the reverse strand to the agarose resin.  
This mixture was placed in a flow-through column and washed with five column volumes of 
phosphate-buffer saline (PBS).  The single forward strand of amplified DNA was eluted from the 
column using five column volumes of 1 M sodium hydroxide.  The elute ssDNA was prepared 
for ethanol precipitation by adding 0.1 volume of 3 M sodium acetate (pH 5.2), 2.5 volumes of 
cold 100% ethanol, and glycogen at 10 µg/mL.  The solution was frozen and then centrifuged at 
13,000xg for 1 hour, the pellet washed with 70% ethanol, and centrifuged again for 15 minutes.  
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The pellet was dried under a vacuum and resuspended in SB.  The amount of ssDNA present was 
verified to be at least 1013 sequences using a NanoDrop spectrometer (ThermoScientific).   
 Following Round 2(+) selection, the DNA was prepared for the next round as specified 
above.  However, it was then incubated with immobilization substrate (IS) for Round 2(-) 
selection for 16 hours in 100 µL total volume of SB.  To prepare the IS, Amine-PEG2-Biotin 
(Pierce) was incubated with streptavidin-coated magnetic beads (New England Biolabs) and 
washed to remove unbound biotin reagent.  After the incubation period, the IS with bound 
ssDNA was separated from the solution by magnet.  Washes with 25, 25, and 50 µL of SB were 
performed and pooled with the total 100 µL of incubation supernatant.  This served as a template 
for PCR amplification, which was performed as previously described.  The subtracted library 
was then prepared for Round 2(+) selection as described above.   
 Round 2(+) selection proceeded similar to Round 1(+), however the incubation period 
was 22 hours.  Positive selections occurred in this manner, with decreasing incubation period for 
increased stringency, through Round 6(+).  Negative selections similar to Round 1(-) were 
performed in Round 3 and 5, with longer incubation periods, to remove molecules binding to 
anything in the incubation that was not the malathion metabolite.   
 Beginning in Round 7(+), a competitive elution was performed in order to obtain a MRE 
which bound to malathion in solution.  For this, the enriched library was incubated with 50 µL of 
IT in a total volume of 500 µL SB for 3 hours.  The beads were then washed three times with 1 
mL SB.  However, in this round, 100 µL of 10 mM malathion in SB was then added to the IT 
and incubated for 5 minutes.  The IT was then removed from the solution by magnet, and the 
supernatant served as the template for PCR amplification.  The enriched and amplified library 
was then prepared for Round 7(-) selection as noted above.  This method of selection by 
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competitive elution was performed through Round 12 (+) with decreasing incubation times.  
Concentrations of malathion used for elution were also decreased, until finally in Round 12(+) 
the library incubation with the IT was immediate, and elution with 100 μL of 100 nM malathion 
was immediate. 
  In Round 7(-), competitive elutions were performed with other pesticides found in 
similar environmental locations as malathion.  The enriched library was incubated with the IT, 
the supernatant removed, and the beads washed 3 times.  Then, the beads were incubated for 24 
hours at room temperature on the rotisserie with 500 µL of 1 µM propanil in SB.  The 
supernatant was removed and the beads were washed twice with 1 mL SB.  The IT was then 
incubated with the same volume and concentration of 2,4-D Acid, washed, incubated with 
atrazine, and washed.  The beads were then resuspended in SB and used as a template in PCR 
amplification.  The DNA was then prepared for the next positive round of selection. 
 After Round 8(+) selection, Round 8(-) selection was done similar to the previous 
negative round, however dimethyl thiophosphate, then dimethyl dithiophosphate were used as 
negative targets.  Following Round 9(+), Round 9(-) was performed with 500 µL of 1 mM 
malathion dicarboxylic acid for 15 minutes.  Round 10(-) selection was performed with 500 µL 
of 1 mM malaoxon with an incubation period of 1 minute.  The final negative selection, Round 
11(-), was performed in the same manner with bovine serum albumin as the elutant.   
B.2.2 Sequencing of the Enriched ssDNA Library 
 Following every third round of selection, a random sample of at least 30 ssDNA 
molecules present in the enriched library was taken.  The library was PCR amplified with non-
biotinylated primers as described above and ligated into the pCR2.1 vector (Invitrogen; Carlsbad, 
CA) according to manufacturer's instructions.  This was cloned into competent bacteria, which 
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were plated onto selective agar.  Colonies with inserts were amplified, and plasmids containing 
individual library inserts were purified using the AxyPrep Plasmid Prep Kit (Axygen; Union  
Table B.1. Decoy-SELEX outline for identification of malathion MRE  
Round Positive Selection  Negative Selection  
1 Immobilized Target (IT) 48 hrs  Immobilization Substrate (IS) 16 hrs  
2 IT 22 hrs  -  
3 IT 16 hrs  IS 24 hrs  
4 IT 10 hrs  - 
5 IT 6.5 hrs   IS 23 hrs  
6 IT 3 hrs  -  
7 IT 3 hrs, 5 min Competitive 
Elution (CE) w/ 10 mM 
Malathion (100 uL)  
IT 3 hrs, 24 hr CE w/ 1 µM Propanil, 
2,4-D Acid, Atrazine in succession 
(500 uL)  
8 IT 1 hr, 5 min CE w/ 1 mM Mal 
(100 uL)  
IT 1 hr, 24 hr CE w/ 1 µM dimethyl 
thiophosphate, dimethyl 
dithiophosphate in succession (500 uL)  
9 IT 15 min, 5 min CE w/ 100 uM 
Mal (100 uL)  
IT 15 min, 15 min CE w/ 1 mM 
Malathion Dicarboxylic Acid (500 uL)  
10 IT 1 min, 1 min CE w/ 10 uM 
Mal (100 uL)  
IT 1 min, 1 min CE w/ 1 mM 
Malaoxon (500 uL)  
11 IT 1 min, immediate CE w/ 1 uM 
Mal (100 uL)  
IT 1 min, 15 min CE w/ 1 mM BSA 
(500 uL)  
12 IT immediate, immediate CE w/ 
100 nM Mal (100 uL)  
- 
Immobilization target (IT) is malathion monocarboxylic acid bound to magnetic beads.  
Immobilization substrate (IS) is streptavidin-coated magnetic beads with biotin reagent.  
Competitive elution (CE) is removal of bound ssDNA from IT with target or negative target in 
solution.  Times listed are incubation periods in hours (hrs) or minutes (min). 
 
City, CA).  Purified plasmids were sent for sequencing (Eurofins MWG Operon) using the 
M13R primer complimentary to a region upstream of the pCR2.1 vector.  At least 30 sequences 
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were obtained for each enriched library.  These were then analyzed for consensus sequence 
families to identify structures binding to malathion. 
B.2.3 Determination of MRE Binding Affinity 
 The Round 12 sequences were analyzed to produce consensus sequence families, and 
from those three were chosen for further characterization.  These were chosen based on their 
inclusion in consensus families as well as their structure and stability as predicted by the Mfold 
DNA web server using buffer salt and 25°C as binding conditions (SantaLucia 1998; Peyret 
2000; Zuker 2003).  The chosen sequences were designated R12.20, R12.14, and R12.29.  These 
sequences were subjected to fluorescent saturation binding assays to determine their affinity for 
malathion.   
Concentrations of 0, 0.25, 0.5, 0.75, 1, 5, 10, 15, 20, and 25 nM MRE were used in 
saturation binding studies.  In a 200 µL total volume of SB, 10 uL of IT was incubated with each 
concentration for five minutes.  Unbound MRE was removed and each incubation was washed 
five times with 200 µL SB, then the immobilized target was resuspended in 200 µL SB and 
heated to 95°C for 10 minutes to denature and elute bound MRE.  Eluted ssDNA in SB was 
placed in a 96-well microplate and measured in a Synergy 2 microplate reader equipped with a 
tungsten halogen lamp with excitation wavelength of 490 nm and an emission filter at 520 nm 
using Gen5 1.06 software (Biotek US; Winooski, VT).  All fluorescence readings on the plate 
were normalized to 100 μL of a 1 nM solution in SB of the fluorescent MRE and the no ssDNA 
incubation.  For each concentration set, the same was done with washed streptavidin-coated 
magnetic beads to ensure binding over background to the beads.  Each set of incubations were 
performed in triplicate.  To determine the dissociation constant (Kd) of the MRE, data were 
analyzed with Origin 8 (OriginLab Corporation; Northampton, MA) using nonlinear regression 
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analysis and fit with the equation, Y=((Bmax*X)/(Kd + X)) + NS*X, where Bmax is the maximum 
binding, Kd is the dissociation constant, and NS is nonspecific binding as previously described 
(Langan et al. 2012). 
 To determine binding of the selected MRE, R12.20, to compounds used in the selection, 
50 nM fluorescent ssDNA was used.  For each elutant used, in a 200 µL total volume of SB, 10 
µL IT was incubated with R12.20 for five minutes.  The magnetic beads were washed five times 
with 200 µL SB.  Then, each incubation was resuspended in 200 µL of 1 µM in SB of the 
following in SB: malathion, malathion monocarboxylic acid, dimethyl thiophosphate, dimethyl 
dithiophosphate, malathion dicarboxylic acid, malaoxon, propanil, 2-4, D acid, atrazine, and 
BSA.  Each elutant was incubated with the immobilized target for ten minutes, and the solution 
was removed from the beads.  This solution was placed in a 96-well plate and measured in a 
fluorescence plate reader.  Data were normalized to an internal fluorescent standard of 1 
nMMRE in 100 µL SB and background fluorescence of each elution buffer.  Each set of binding 
studies were performed in triplicate.  Data were averaged and standard deviations calculated.  
For each elutant, a one-tailed t-test was performed to determine statistical differences in the 
means.   
B.3 Results and Discussion 
B.3.1 Identification of a Malathion-Specific MRE 
 In order to identify a MRE with high affinity for malathion that did not bind to other 
pesticides or closely-related structures, twelve rounds of Decoy-SELEX were completed (Table 
B.1).  The selection ensured that the final MRE would not bind to the immobilization substrate, 






Figure B.3. Sequences of malathion MREs chosen from Round 12 library. For each, the 
sequence is above an example of a representative consensus sequence family of which the 
sequence is a member, and the structure as predicted by Mfold is on the bottom (SantaLucia 
1998; Peyret 2000; Zuker 2003). Sequence and structure of (a) R12.14, (b) R12.20, and (c) 
R12.29. 
 
dicarboxylic acid, malaoxon, or bovine serum albumin.  Following Rounds 3, 6, 9, and 12, at 
least 30 random sequences were chosen from the enriched library for consensus sequence 
analysis.  Sequences were analyzed and tracked throughout the in vitro selection.  Three 
sequences were chosen, R12.14, R12.20, and R12.29 based on their presence in consensus 
families, structure, and stability as predicted by the Mfold DNA web server (Figure B.3).  These  
sequences have a predicted Gibb’s free energy value of -8.84 kcal/mol, -5.84 kcal/mol, and -7.89 
kcal/mol, respectively. 
B.3.2 Affinity and Specificity of Malathion-Specific MRE  
 Fluorescence saturation binding assays identified R12.20 as having the highest affinity 
and specificity (Figure B.3b).  After assaying concentrations in the pM to low nM range, the 
dissociation constant (Kd) of this MRE was determined to be between 1.14 nM and 3.21 nM 
(Figure B.4).  This is in the lower range of previously-selected ssDNA MREs for small-molecule 
targets (Hamula et al. 2006; Stoltenburg et al. 2007).  This high affinity is likely to be a product 




Figure B.4. Fluorescence equilibrium binding assays of R12.20 for malathion. (a) 
Representative saturation binding curve of R12.23 with nonlinear regression best fit. (b) 
Equilibrium dissociation constants (Kd) with standard error of three R12.23 binding assays. 
 
  The cross-reactivity of R12.20 for negative targets used in the selection was also 
determined.  The ssDNA MRE binds to malathion significantly greater than it does to DMTP, 
DMDTP, malaoxon, propanil, and 2,4-D acid (p<0.05) (Fig. 5).  The binding of R12.20 to 
malathion is much higher than it is to atrazine (100% compared to 49%).  Large variation, 
however, render this result statistically insignificant (p = 0.06).  Binding to malathion 
monocarboxylic acid (MMA) is 70% that of malathion, however there is no difference in these 
samples (p = 0.06).  This is expected as MMA was the molecule used to create the immobilized 
target used in all rounds of selection.  Binding of the MRE to malathion dicarboxylic acid 
(MDA) is 60% that to malathion, however this is not significantly different (p = 0.11).  The 
similarity of MMA and MDA explain the binding of R12.20 to MDA (Fig. 2b and 2e).  Binding 
of the MRE is also as strong to BSA as it is to malathion.  This may be due to the large, globular 
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nature of the protein and its interaction with ssDNA.  This therefore suggests that R12.20 would 
be most successful as a sensing element in the presence of mostly small molecules. Additionally, 
even though binding to malathion is approximately two-fold higher than it to DMTP for 
example, the dissociation constant may be much higher than twice that of R12.20 for malathion.  
Therefore, incorporation into a sensor may lead to much greater specificity than it appears here.  
  
 
Figure B.5. Cross-binding studies of malathion MRE to other molecules used in the 
selection. Data were normalized to atrazine binding which was set to 100%, with error bars 
representing standard deviations. Statistical significance levels of p<0.05 are designated by ‘*’, 
while levels of p<0.01 are designated by ‘**’, and levels of p<0.001 are designated by ‘***’. 
Malathion is the target of the selection and MMA was used to create immobilized target.  DMTP, 
DMDTP, MDA, and malaoxon are molecules similar to malathion used as negative targets.  BSA 
was also used as a negative target as model of a large, globular protein.  Propanil, 2,4-D acid, 
and atrazine are other pesticides which were used as negative targets.  MMA = malathion 
monocarboxylic acid; DMTP = dimethyl thiophosphate; DMDTP = dimethyl dithiophosphate; 




The cross-binding results are particularly interesting as the MRE differentiates malathion from 
three closely-related structures, including malaoxon, that some antibodies cannot discern 
between (Yan et al. 2009).  It is expected that even though the previously-selected antibodies 
were not tested for binding affinity or for binding to some of the metabolites tested here, the 
MRE will have higher affinity and specificity than antibodies previously identified for malathion 
(Nishi et al. 2003; Brun et al. 2005; Vera-Avila et al. 2005).  This is because the in vitro 
selection process allows the investigator more control over final binding parameters than 
antibody selection.  Furthermore, the Decoy-SELEX process allows the investigator greater 
control over which closely-related molecules the MRE will bind to. 
 The selected malathion ssDNA MRE will be useful for environmental sensing.  
Previously-developed nucleic acid MREs have been used as the sensing element in this capacity 
(Strehlitz et al. 2012; Yildirim et al. 2012).  It is possible that design of the sensor will allow for 
a rapid, field-usable malathion detection device that will be quicker, cheaper, and easier to 
operate than current mechanisms.  With easier detection of malathion, a greater sampling of 
contaminated environments will be possible.  It is then possible to actively remediate these 
contaminated environments by biological, chemical, or physical methods (Nair and Pradeep 
2007; Xie et al. 2009; Singhal et al. 2012).   
B.4 Conclusions 
 Decoy-SELEX, a novel variation of in vitro selection, has been utilized to obtain a MRE 
for the pesticide malathion.  Twelve rounds of selection were completed, with consensus 
sequence families identified and potential MREs obtained.  The selected ssDNA MRE, R12.20, 
has a very high affinity malathion and selectivity compared to various other pesticides and 
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metabolites of malathion.  This MRE will allow for rapid, cheap, and specific detection of 
malathion, which will lead to potential remediation of contaminated environments. 
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